ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine
Identifieur interne : 000105 ( Pmc/Corpus ); précédent : 000104; suivant : 000106ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine
Auteurs : Jinjiao Hu ; Yanhao Zhang ; Xiuxing Jiang ; Hongwei Zhang ; Ziyi Gao ; Yunong Li ; Ruoqiu Fu ; Lirong Li ; Jie Li ; Hongjuan Cui ; Ning GaoSource :
- Journal of Experimental & Clinical Cancer Research : CR [ 0392-9078 ] ; 2019.
Abstract
Triple-negative breast cancer (TNBC) is often aggressive and associated with a poor prognosis. Due to the lack of available targeted therapies and to problems of resistance with conventional chemotherapeutic agents, finding new treatments for TNBC remains a challenge and a better therapeutic strategy is urgently required.
TNBC cells and xenograft mice were treated with a combination of chloroquine (CQ) and isorhamnetin (IH). Mitochondrial fission, apoptosis, and related signaling pathways were determined by flow cytometry, immunofluorescence, and related molecular biological techniques.
The inhibition of autophagy/mitophagy by CQ selectively enhances IH-induced mitochondrial fission and apoptosis in TNBC cells but not in estrogen-dependent breast cancer cells. These events were accompanied by mitochondrial translocation of Bax and the release of cytochrome c. Mechanistically, these effects were associated with oxidative stress-mediated phosphorylation of CaMKII (Thr286) and Drp1 (S616), and subsequent mitochondrial translocation of CaMKII and Drp1. The interruption of the CaMKII pathway by genetic approaches (e.g. CaMKII mutant or siRNA) attenuated combination-mediated mitochondrial fission and apoptosis. The combination of CQ/IH was a marked inhibitor tumor growth, inducing apoptosis in the TNBC xenograft mouse model in association with the activation of CaMKII and Drp1 (S616).
Our study highlights the critical role of ROS-mediating CaMKII/Drp1 signaling in the regulation of mitochondrial fission and apoptosis induced by combination of CQ/IH. These findings also suggest that IH could potentially be further developed as a novel chemotherapeutic agent. Furthermore, a combination of IH with classic autophagy/mitophagy inhibitor could represent a novel therapeutic strategy for the treatment of TNBC.
The online version of this article (10.1186/s13046-019-1201-4) contains supplementary material, which is available to authorized users.
Url:
DOI: 10.1186/s13046-019-1201-4
PubMed: 31138329
PubMed Central: 6540563
Links to Exploration step
PMC:6540563Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine</title><author><name sortKey="Hu, Jinjiao" sort="Hu, Jinjiao" uniqKey="Hu J" first="Jinjiao" last="Hu">Jinjiao Hu</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Zhang, Yanhao" sort="Zhang, Yanhao" uniqKey="Zhang Y" first="Yanhao" last="Zhang">Yanhao Zhang</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Jiang, Xiuxing" sort="Jiang, Xiuxing" uniqKey="Jiang X" first="Xiuxing" last="Jiang">Xiuxing Jiang</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Zhang, Hongwei" sort="Zhang, Hongwei" uniqKey="Zhang H" first="Hongwei" last="Zhang">Hongwei Zhang</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Gao, Ziyi" sort="Gao, Ziyi" uniqKey="Gao Z" first="Ziyi" last="Gao">Ziyi Gao</name><affiliation><nlm:aff id="Aff3">Greater Philadelphia Pharmacy, Philadelphia, USA</nlm:aff></affiliation></author><author><name sortKey="Li, Yunong" sort="Li, Yunong" uniqKey="Li Y" first="Yunong" last="Li">Yunong Li</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Fu, Ruoqiu" sort="Fu, Ruoqiu" uniqKey="Fu R" first="Ruoqiu" last="Fu">Ruoqiu Fu</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Li, Lirong" sort="Li, Lirong" uniqKey="Li L" first="Lirong" last="Li">Lirong Li</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Li, Jie" sort="Li, Jie" uniqKey="Li J" first="Jie" last="Li">Jie Li</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Cui, Hongjuan" sort="Cui, Hongjuan" uniqKey="Cui H" first="Hongjuan" last="Cui">Hongjuan Cui</name><affiliation><nlm:aff id="Aff4"><institution-wrap><institution-id institution-id-type="GRID">grid.263906.8</institution-id><institution>State Key Laboratory of Silkworm Genome Biology,</institution><institution>Southwest University,</institution></institution-wrap>2#Tiansheng Road, Beibei District, Chongqing, 400716 China</nlm:aff></affiliation><affiliation><nlm:aff id="Aff5"><institution-wrap><institution-id institution-id-type="GRID">grid.263906.8</institution-id><institution>Medical Research Institute, Southwest University,</institution></institution-wrap>2#Tiansheng Road, Beibei District, Chongqing, 400716 China</nlm:aff></affiliation></author><author><name sortKey="Gao, Ning" sort="Gao, Ning" uniqKey="Gao N" first="Ning" last="Gao">Ning Gao</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0240 6969</institution-id><institution-id institution-id-type="GRID">grid.417409.f</institution-id><institution>Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education,</institution><institution>Zunyi Medical University,</institution></institution-wrap>Zunyi, China</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">31138329</idno><idno type="pmc">6540563</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540563</idno><idno type="RBID">PMC:6540563</idno><idno type="doi">10.1186/s13046-019-1201-4</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">000105</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000105</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine</title><author><name sortKey="Hu, Jinjiao" sort="Hu, Jinjiao" uniqKey="Hu J" first="Jinjiao" last="Hu">Jinjiao Hu</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Zhang, Yanhao" sort="Zhang, Yanhao" uniqKey="Zhang Y" first="Yanhao" last="Zhang">Yanhao Zhang</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Jiang, Xiuxing" sort="Jiang, Xiuxing" uniqKey="Jiang X" first="Xiuxing" last="Jiang">Xiuxing Jiang</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Zhang, Hongwei" sort="Zhang, Hongwei" uniqKey="Zhang H" first="Hongwei" last="Zhang">Hongwei Zhang</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Gao, Ziyi" sort="Gao, Ziyi" uniqKey="Gao Z" first="Ziyi" last="Gao">Ziyi Gao</name><affiliation><nlm:aff id="Aff3">Greater Philadelphia Pharmacy, Philadelphia, USA</nlm:aff></affiliation></author><author><name sortKey="Li, Yunong" sort="Li, Yunong" uniqKey="Li Y" first="Yunong" last="Li">Yunong Li</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Fu, Ruoqiu" sort="Fu, Ruoqiu" uniqKey="Fu R" first="Ruoqiu" last="Fu">Ruoqiu Fu</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Li, Lirong" sort="Li, Lirong" uniqKey="Li L" first="Lirong" last="Li">Lirong Li</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Li, Jie" sort="Li, Jie" uniqKey="Li J" first="Jie" last="Li">Jie Li</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation></author><author><name sortKey="Cui, Hongjuan" sort="Cui, Hongjuan" uniqKey="Cui H" first="Hongjuan" last="Cui">Hongjuan Cui</name><affiliation><nlm:aff id="Aff4"><institution-wrap><institution-id institution-id-type="GRID">grid.263906.8</institution-id><institution>State Key Laboratory of Silkworm Genome Biology,</institution><institution>Southwest University,</institution></institution-wrap>2#Tiansheng Road, Beibei District, Chongqing, 400716 China</nlm:aff></affiliation><affiliation><nlm:aff id="Aff5"><institution-wrap><institution-id institution-id-type="GRID">grid.263906.8</institution-id><institution>Medical Research Institute, Southwest University,</institution></institution-wrap>2#Tiansheng Road, Beibei District, Chongqing, 400716 China</nlm:aff></affiliation></author><author><name sortKey="Gao, Ning" sort="Gao, Ning" uniqKey="Gao N" first="Ning" last="Gao">Ning Gao</name><affiliation><nlm:aff id="Aff1">College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</nlm:aff></affiliation><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0240 6969</institution-id><institution-id institution-id-type="GRID">grid.417409.f</institution-id><institution>Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education,</institution><institution>Zunyi Medical University,</institution></institution-wrap>Zunyi, China</nlm:aff></affiliation></author></analytic><series><title level="j">Journal of Experimental & Clinical Cancer Research : CR</title><idno type="ISSN">0392-9078</idno><idno type="eISSN">1756-9966</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p id="Par1">Triple-negative breast cancer (TNBC) is often aggressive and associated with a poor prognosis. Due to the lack of available targeted therapies and to problems of resistance with conventional chemotherapeutic agents, finding new treatments for TNBC remains a challenge and a better therapeutic strategy is urgently required.</p></sec><sec><title>Methods</title><p id="Par2">TNBC cells and xenograft mice were treated with a combination of chloroquine (CQ) and isorhamnetin (IH). Mitochondrial fission, apoptosis, and related signaling pathways were determined by flow cytometry, immunofluorescence, and related molecular biological techniques.</p></sec><sec><title>Results</title><p id="Par3">The inhibition of autophagy/mitophagy by CQ selectively enhances IH-induced mitochondrial fission and apoptosis in TNBC cells but not in estrogen-dependent breast cancer cells. These events were accompanied by mitochondrial translocation of Bax and the release of cytochrome c. Mechanistically, these effects were associated with oxidative stress-mediated phosphorylation of CaMKII (Thr286) and Drp1 (S616), and subsequent mitochondrial translocation of CaMKII and Drp1. The interruption of the CaMKII pathway by genetic approaches (e.g. CaMKII mutant or siRNA) attenuated combination-mediated mitochondrial fission and apoptosis. The combination of CQ/IH was a marked inhibitor tumor growth, inducing apoptosis in the TNBC xenograft mouse model in association with the activation of CaMKII and Drp1 (S616).</p></sec><sec><title>Conclusions</title><p id="Par4">Our study highlights the critical role of ROS-mediating CaMKII/Drp1 signaling in the regulation of mitochondrial fission and apoptosis induced by combination of CQ/IH. These findings also suggest that IH could potentially be further developed as a novel chemotherapeutic agent. Furthermore, a combination of IH with classic autophagy/mitophagy inhibitor could represent a novel therapeutic strategy for the treatment of TNBC.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13046-019-1201-4) contains supplementary material, which is available to authorized users.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Nagini, S" uniqKey="Nagini S">S Nagini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dietze, Ec" uniqKey="Dietze E">EC Dietze</name></author><author><name sortKey="Sistrunk, C" uniqKey="Sistrunk C">C Sistrunk</name></author><author><name sortKey="Miranda Carboni, G" uniqKey="Miranda Carboni G">G Miranda-Carboni</name></author><author><name sortKey="O Regan, R" uniqKey="O Regan R">R O'Regan</name></author><author><name sortKey="Seewaldt, Vl" uniqKey="Seewaldt V">VL Seewaldt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yao, H" uniqKey="Yao H">H Yao</name></author><author><name sortKey="He, G" uniqKey="He G">G He</name></author><author><name sortKey="Yan, S" uniqKey="Yan S">S Yan</name></author><author><name sortKey="Chen, C" uniqKey="Chen C">C Chen</name></author><author><name sortKey="Song, L" uniqKey="Song L">L Song</name></author><author><name sortKey="Rosol, Tj" uniqKey="Rosol T">TJ Rosol</name></author><author><name sortKey="Deng, X" uniqKey="Deng X">X Deng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wu, N" uniqKey="Wu N">N Wu</name></author><author><name sortKey="Zhang, J" uniqKey="Zhang J">J Zhang</name></author><author><name sortKey="Zhao, J" uniqKey="Zhao J">J Zhao</name></author><author><name sortKey="Mu, K" uniqKey="Mu K">K Mu</name></author><author><name sortKey="Zhang, J" uniqKey="Zhang J">J Zhang</name></author><author><name sortKey="Jin, Z" uniqKey="Jin Z">Z Jin</name></author><author><name sortKey="Yu, J" uniqKey="Yu J">J Yu</name></author><author><name sortKey="Liu, J" uniqKey="Liu J">J Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chun, Kh" uniqKey="Chun K">KH Chun</name></author><author><name sortKey="Park, Jh" uniqKey="Park J">JH Park</name></author><author><name sortKey="Fan, S" uniqKey="Fan S">S Fan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nunez, C" uniqKey="Nunez C">C Nunez</name></author><author><name sortKey="Capelo, Jl" uniqKey="Capelo J">JL Capelo</name></author><author><name sortKey="Igrejas, G" uniqKey="Igrejas G">G Igrejas</name></author><author><name sortKey="Alfonso, A" uniqKey="Alfonso A">A Alfonso</name></author><author><name sortKey="Botana, Lm" uniqKey="Botana L">LM Botana</name></author><author><name sortKey="Lodeiro, C" uniqKey="Lodeiro C">C Lodeiro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Limpert, As" uniqKey="Limpert A">AS Limpert</name></author><author><name sortKey="Lambert, Lj" uniqKey="Lambert L">LJ Lambert</name></author><author><name sortKey="Bakas, Na" uniqKey="Bakas N">NA Bakas</name></author><author><name sortKey="Bata, N" uniqKey="Bata N">N Bata</name></author><author><name sortKey="Brun, Sn" uniqKey="Brun S">SN Brun</name></author><author><name sortKey="Shaw, Rj" uniqKey="Shaw R">RJ Shaw</name></author><author><name sortKey="Cosford, Ndp" uniqKey="Cosford N">NDP Cosford</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Pagotto, A" uniqKey="Pagotto A">A Pagotto</name></author><author><name sortKey="Pilotto, G" uniqKey="Pilotto G">G Pilotto</name></author><author><name sortKey="Mazzoldi, El" uniqKey="Mazzoldi E">EL Mazzoldi</name></author><author><name sortKey="Nicoletto, Mo" uniqKey="Nicoletto M">MO Nicoletto</name></author><author><name sortKey="Frezzini, S" uniqKey="Frezzini S">S Frezzini</name></author><author><name sortKey="Pasto, A" uniqKey="Pasto A">A Pasto</name></author><author><name sortKey="Amadori, A" uniqKey="Amadori A">A Amadori</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Thomas, S" uniqKey="Thomas S">S Thomas</name></author><author><name sortKey="Sharma, N" uniqKey="Sharma N">N Sharma</name></author><author><name sortKey="Golden, Eb" uniqKey="Golden E">EB Golden</name></author><author><name sortKey="Cho, H" uniqKey="Cho H">H Cho</name></author><author><name sortKey="Agarwal, P" uniqKey="Agarwal P">P Agarwal</name></author><author><name sortKey="Gaffney, Kj" uniqKey="Gaffney K">KJ Gaffney</name></author><author><name sortKey="Petasis, Na" uniqKey="Petasis N">NA Petasis</name></author><author><name sortKey="Chen, Tc" uniqKey="Chen T">TC Chen</name></author><author><name sortKey="Hofman, Fm" uniqKey="Hofman F">FM Hofman</name></author><author><name sortKey="Louie, Sg" uniqKey="Louie S">SG Louie</name></author><author><name sortKey="Schonthal, Ah" uniqKey="Schonthal A">AH Schonthal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lefort, S" uniqKey="Lefort S">S Lefort</name></author><author><name sortKey="Joffre, C" uniqKey="Joffre C">C Joffre</name></author><author><name sortKey="Kieffer, Y" uniqKey="Kieffer Y">Y Kieffer</name></author><author><name sortKey="Givel, Am" uniqKey="Givel A">AM Givel</name></author><author><name sortKey="Bourachot, B" uniqKey="Bourachot B">B Bourachot</name></author><author><name sortKey="Zago, G" uniqKey="Zago G">G Zago</name></author><author><name sortKey="Bieche, I" uniqKey="Bieche I">I Bieche</name></author><author><name sortKey="Dubois, T" uniqKey="Dubois T">T Dubois</name></author><author><name sortKey="Meseure, D" uniqKey="Meseure D">D Meseure</name></author><author><name sortKey="Vincent Salomon, A" uniqKey="Vincent Salomon A">A Vincent-Salomon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yeh, Sl" uniqKey="Yeh S">SL Yeh</name></author><author><name sortKey="Lin, Yc" uniqKey="Lin Y">YC Lin</name></author><author><name sortKey="Lin, Yl" uniqKey="Lin Y">YL Lin</name></author><author><name sortKey="Li, Cc" uniqKey="Li C">CC Li</name></author><author><name sortKey="Chuang, Ch" uniqKey="Chuang C">CH Chuang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ruan, Y" uniqKey="Ruan Y">Y Ruan</name></author><author><name sortKey="Hu, K" uniqKey="Hu K">K Hu</name></author><author><name sortKey="Chen, H" uniqKey="Chen H">H Chen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ma, G" uniqKey="Ma G">G Ma</name></author><author><name sortKey="Yang, C" uniqKey="Yang C">C Yang</name></author><author><name sortKey="Qu, Y" uniqKey="Qu Y">Y Qu</name></author><author><name sortKey="Wei, H" uniqKey="Wei H">H Wei</name></author><author><name sortKey="Zhang, T" uniqKey="Zhang T">T Zhang</name></author><author><name sortKey="Zhang, N" uniqKey="Zhang N">N Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ramachandran, L" uniqKey="Ramachandran L">L Ramachandran</name></author><author><name sortKey="Manu, Ka" uniqKey="Manu K">KA Manu</name></author><author><name sortKey="Shanmugam, Mk" uniqKey="Shanmugam M">MK Shanmugam</name></author><author><name sortKey="Li, F" uniqKey="Li F">F Li</name></author><author><name sortKey="Siveen, Ks" uniqKey="Siveen K">KS Siveen</name></author><author><name sortKey="Vali, S" uniqKey="Vali S">S Vali</name></author><author><name sortKey="Kapoor, S" uniqKey="Kapoor S">S Kapoor</name></author><author><name sortKey="Abbasi, T" uniqKey="Abbasi T">T Abbasi</name></author><author><name sortKey="Surana, R" uniqKey="Surana R">R Surana</name></author><author><name sortKey="Smoot, Dt" uniqKey="Smoot D">DT Smoot</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Saud, Sm" uniqKey="Saud S">SM Saud</name></author><author><name sortKey="Young, Mr" uniqKey="Young M">MR Young</name></author><author><name sortKey="Jones Hall, Yl" uniqKey="Jones Hall Y">YL Jones-Hall</name></author><author><name sortKey="Ileva, L" uniqKey="Ileva L">L Ileva</name></author><author><name sortKey="Evbuomwan, Mo" uniqKey="Evbuomwan M">MO Evbuomwan</name></author><author><name sortKey="Wise, J" uniqKey="Wise J">J Wise</name></author><author><name sortKey="Colburn, Nh" uniqKey="Colburn N">NH Colburn</name></author><author><name sortKey="Kim, Ys" uniqKey="Kim Y">YS Kim</name></author><author><name sortKey="Bobe, G" uniqKey="Bobe G">G Bobe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, Je" uniqKey="Kim J">JE Kim</name></author><author><name sortKey="Lee, De" uniqKey="Lee D">DE Lee</name></author><author><name sortKey="Lee, Kw" uniqKey="Lee K">KW Lee</name></author><author><name sortKey="Son, Je" uniqKey="Son J">JE Son</name></author><author><name sortKey="Seo, Sk" uniqKey="Seo S">SK Seo</name></author><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author><author><name sortKey="Jung, Sk" uniqKey="Jung S">SK Jung</name></author><author><name sortKey="Heo, Ys" uniqKey="Heo Y">YS Heo</name></author><author><name sortKey="Mottamal, M" uniqKey="Mottamal M">M Mottamal</name></author><author><name sortKey="Bode, Am" uniqKey="Bode A">AM Bode</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hu, S" uniqKey="Hu S">S Hu</name></author><author><name sortKey="Huang, L" uniqKey="Huang L">L Huang</name></author><author><name sortKey="Meng, L" uniqKey="Meng L">L Meng</name></author><author><name sortKey="Sun, H" uniqKey="Sun H">H Sun</name></author><author><name sortKey="Zhang, W" uniqKey="Zhang W">W Zhang</name></author><author><name sortKey="Xu, Y" uniqKey="Xu Y">Y Xu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, Hw" uniqKey="Zhang H">HW Zhang</name></author><author><name sortKey="Hu, Jj" uniqKey="Hu J">JJ Hu</name></author><author><name sortKey="Fu, Rq" uniqKey="Fu R">RQ Fu</name></author><author><name sortKey="Liu, X" uniqKey="Liu X">X Liu</name></author><author><name sortKey="Zhang, Yh" uniqKey="Zhang Y">YH Zhang</name></author><author><name sortKey="Li, J" uniqKey="Li J">J Li</name></author><author><name sortKey="Liu, L" uniqKey="Liu L">L Liu</name></author><author><name sortKey="Li, Yn" uniqKey="Li Y">YN Li</name></author><author><name sortKey="Deng, Q" uniqKey="Deng Q">Q Deng</name></author><author><name sortKey="Luo, Qs" uniqKey="Luo Q">QS Luo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gao, N" uniqKey="Gao N">N Gao</name></author><author><name sortKey="Kramer, L" uniqKey="Kramer L">L Kramer</name></author><author><name sortKey="Rahmani, M" uniqKey="Rahmani M">M Rahmani</name></author><author><name sortKey="Dent, P" uniqKey="Dent P">P Dent</name></author><author><name sortKey="Grant, S" uniqKey="Grant S">S Grant</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, G" uniqKey="Li G">G Li</name></author><author><name sortKey="Zhou, J" uniqKey="Zhou J">J Zhou</name></author><author><name sortKey="Budhraja, A" uniqKey="Budhraja A">A Budhraja</name></author><author><name sortKey="Hu, X" uniqKey="Hu X">X Hu</name></author><author><name sortKey="Chen, Y" uniqKey="Chen Y">Y Chen</name></author><author><name sortKey="Cheng, Q" uniqKey="Cheng Q">Q Cheng</name></author><author><name sortKey="Liu, L" uniqKey="Liu L">L Liu</name></author><author><name sortKey="Zhou, T" uniqKey="Zhou T">T Zhou</name></author><author><name sortKey="Li, P" uniqKey="Li P">P Li</name></author><author><name sortKey="Liu, E" uniqKey="Liu E">E Liu</name></author><author><name sortKey="Gao, N" uniqKey="Gao N">N Gao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, G" uniqKey="Li G">G Li</name></author><author><name sortKey="Zhou, T" uniqKey="Zhou T">T Zhou</name></author><author><name sortKey="Liu, L" uniqKey="Liu L">L Liu</name></author><author><name sortKey="Chen, J" uniqKey="Chen J">J Chen</name></author><author><name sortKey="Zhao, Z" uniqKey="Zhao Z">Z Zhao</name></author><author><name sortKey="Peng, Y" uniqKey="Peng Y">Y Peng</name></author><author><name sortKey="Li, P" uniqKey="Li P">P Li</name></author><author><name sortKey="Gao, N" uniqKey="Gao N">N Gao</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sheridan, C" uniqKey="Sheridan C">C Sheridan</name></author><author><name sortKey="Delivani, P" uniqKey="Delivani P">P Delivani</name></author><author><name sortKey="Cullen, Sp" uniqKey="Cullen S">SP Cullen</name></author><author><name sortKey="Martin, Sj" uniqKey="Martin S">SJ Martin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Archer, Sl" uniqKey="Archer S">SL Archer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tanaka, A" uniqKey="Tanaka A">A Tanaka</name></author><author><name sortKey="Youle, Rj" uniqKey="Youle R">RJ Youle</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xu, S" uniqKey="Xu S">S Xu</name></author><author><name sortKey="Wang, P" uniqKey="Wang P">P Wang</name></author><author><name sortKey="Zhang, H" uniqKey="Zhang H">H Zhang</name></author><author><name sortKey="Gong, G" uniqKey="Gong G">G Gong</name></author><author><name sortKey="Gutierrez Cortes, N" uniqKey="Gutierrez Cortes N">N Gutierrez Cortes</name></author><author><name sortKey="Zhu, W" uniqKey="Zhu W">W Zhu</name></author><author><name sortKey="Yoon, Y" uniqKey="Yoon Y">Y Yoon</name></author><author><name sortKey="Tian, R" uniqKey="Tian R">R Tian</name></author><author><name sortKey="Wang, W" uniqKey="Wang W">W Wang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Takemoto Kimura, S" uniqKey="Takemoto Kimura S">S Takemoto-Kimura</name></author><author><name sortKey="Suzuki, K" uniqKey="Suzuki K">K Suzuki</name></author><author><name sortKey="Horigane, Si" uniqKey="Horigane S">SI Horigane</name></author><author><name sortKey="Kamijo, S" uniqKey="Kamijo S">S Kamijo</name></author><author><name sortKey="Inoue, M" uniqKey="Inoue M">M Inoue</name></author><author><name sortKey="Sakamoto, M" uniqKey="Sakamoto M">M Sakamoto</name></author><author><name sortKey="Fujii, H" uniqKey="Fujii H">H Fujii</name></author><author><name sortKey="Bito, H" uniqKey="Bito H">H Bito</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wagner, S" uniqKey="Wagner S">S Wagner</name></author><author><name sortKey="Ruff, Hm" uniqKey="Ruff H">HM Ruff</name></author><author><name sortKey="Weber, Sl" uniqKey="Weber S">SL Weber</name></author><author><name sortKey="Bellmann, S" uniqKey="Bellmann S">S Bellmann</name></author><author><name sortKey="Sowa, T" uniqKey="Sowa T">T Sowa</name></author><author><name sortKey="Schulte, T" uniqKey="Schulte T">T Schulte</name></author><author><name sortKey="Anderson, Me" uniqKey="Anderson M">ME Anderson</name></author><author><name sortKey="Grandi, E" uniqKey="Grandi E">E Grandi</name></author><author><name sortKey="Bers, Dm" uniqKey="Bers D">DM Bers</name></author><author><name sortKey="Backs, J" uniqKey="Backs J">J Backs</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Anderson, Me" uniqKey="Anderson M">ME Anderson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gao, N" uniqKey="Gao N">N Gao</name></author><author><name sortKey="Rahmani, M" uniqKey="Rahmani M">M Rahmani</name></author><author><name sortKey="Dent, P" uniqKey="Dent P">P Dent</name></author><author><name sortKey="Grant, S" uniqKey="Grant S">S Grant</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Maghzal, Gj" uniqKey="Maghzal G">GJ Maghzal</name></author><author><name sortKey="Krause, Kh" uniqKey="Krause K">KH Krause</name></author><author><name sortKey="Stocker, R" uniqKey="Stocker R">R Stocker</name></author><author><name sortKey="Jaquet, V" uniqKey="Jaquet V">V Jaquet</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Talukdar, S" uniqKey="Talukdar S">S Talukdar</name></author><author><name sortKey="Pradhan, Ak" uniqKey="Pradhan A">AK Pradhan</name></author><author><name sortKey="Bhoopathi, P" uniqKey="Bhoopathi P">P Bhoopathi</name></author><author><name sortKey="Shen, Xn" uniqKey="Shen X">XN Shen</name></author><author><name sortKey="August, La" uniqKey="August L">LA August</name></author><author><name sortKey="Windle, Jj" uniqKey="Windle J">JJ Windle</name></author><author><name sortKey="Sarkar, D" uniqKey="Sarkar D">D Sarkar</name></author><author><name sortKey="Furnari, Fb" uniqKey="Furnari F">FB Furnari</name></author><author><name sortKey="Cavenee, Wk" uniqKey="Cavenee W">WK Cavenee</name></author><author><name sortKey="Das, Sk" uniqKey="Das S">SK Das</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshida, Gj" uniqKey="Yoshida G">GJ Yoshida</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yoshida, Gj" uniqKey="Yoshida G">GJ Yoshida</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, Z" uniqKey="Zhang Z">Z Zhang</name></author><author><name sortKey="Liu, L" uniqKey="Liu L">L Liu</name></author><author><name sortKey="Wu, S" uniqKey="Wu S">S Wu</name></author><author><name sortKey="Xing, D" uniqKey="Xing D">D Xing</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bo, T" uniqKey="Bo T">T Bo</name></author><author><name sortKey="Yamamori, T" uniqKey="Yamamori T">T Yamamori</name></author><author><name sortKey="Suzuki, M" uniqKey="Suzuki M">M Suzuki</name></author><author><name sortKey="Sakai, Y" uniqKey="Sakai Y">Y Sakai</name></author><author><name sortKey="Yamamoto, K" uniqKey="Yamamoto K">K Yamamoto</name></author><author><name sortKey="Inanami, O" uniqKey="Inanami O">O Inanami</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ban Ishihara, R" uniqKey="Ban Ishihara R">R Ban-Ishihara</name></author><author><name sortKey="Ishihara, T" uniqKey="Ishihara T">T Ishihara</name></author><author><name sortKey="Sasaki, N" uniqKey="Sasaki N">N Sasaki</name></author><author><name sortKey="Mihara, K" uniqKey="Mihara K">K Mihara</name></author><author><name sortKey="Ishihara, N" uniqKey="Ishihara N">N Ishihara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhou, L" uniqKey="Zhou L">L Zhou</name></author><author><name sortKey="Zhang, Q" uniqKey="Zhang Q">Q Zhang</name></author><author><name sortKey="Zhang, P" uniqKey="Zhang P">P Zhang</name></author><author><name sortKey="Sun, L" uniqKey="Sun L">L Sun</name></author><author><name sortKey="Peng, C" uniqKey="Peng C">C Peng</name></author><author><name sortKey="Yuan, Z" uniqKey="Yuan Z">Z Yuan</name></author><author><name sortKey="Cheng, J" uniqKey="Cheng J">J Cheng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chou, Ch" uniqKey="Chou C">CH Chou</name></author><author><name sortKey="Lin, Cc" uniqKey="Lin C">CC Lin</name></author><author><name sortKey="Yang, Mc" uniqKey="Yang M">MC Yang</name></author><author><name sortKey="Wei, Cc" uniqKey="Wei C">CC Wei</name></author><author><name sortKey="Liao, Hd" uniqKey="Liao H">HD Liao</name></author><author><name sortKey="Lin, Rc" uniqKey="Lin R">RC Lin</name></author><author><name sortKey="Tu, Wy" uniqKey="Tu W">WY Tu</name></author><author><name sortKey="Kao, Tc" uniqKey="Kao T">TC Kao</name></author><author><name sortKey="Hsu, Cm" uniqKey="Hsu C">CM Hsu</name></author><author><name sortKey="Cheng, Jt" uniqKey="Cheng J">JT Cheng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chang, Cr" uniqKey="Chang C">CR Chang</name></author><author><name sortKey="Blackstone, C" uniqKey="Blackstone C">C Blackstone</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Taguchi, N" uniqKey="Taguchi N">N Taguchi</name></author><author><name sortKey="Ishihara, N" uniqKey="Ishihara N">N Ishihara</name></author><author><name sortKey="Jofuku, A" uniqKey="Jofuku A">A Jofuku</name></author><author><name sortKey="Oka, T" uniqKey="Oka T">T Oka</name></author><author><name sortKey="Mihara, K" uniqKey="Mihara K">K Mihara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Korytowski, W" uniqKey="Korytowski W">W Korytowski</name></author><author><name sortKey="Basova, Lv" uniqKey="Basova L">LV Basova</name></author><author><name sortKey="Pilat, A" uniqKey="Pilat A">A Pilat</name></author><author><name sortKey="Kernstock, Rm" uniqKey="Kernstock R">RM Kernstock</name></author><author><name sortKey="Girotti, Aw" uniqKey="Girotti A">AW Girotti</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tang, Q" uniqKey="Tang Q">Q Tang</name></author><author><name sortKey="Liu, W" uniqKey="Liu W">W Liu</name></author><author><name sortKey="Zhang, Q" uniqKey="Zhang Q">Q Zhang</name></author><author><name sortKey="Huang, J" uniqKey="Huang J">J Huang</name></author><author><name sortKey="Hu, C" uniqKey="Hu C">C Hu</name></author><author><name sortKey="Liu, Y" uniqKey="Liu Y">Y Liu</name></author><author><name sortKey="Wang, Q" uniqKey="Wang Q">Q Wang</name></author><author><name sortKey="Zhou, M" uniqKey="Zhou M">M Zhou</name></author><author><name sortKey="Lai, W" uniqKey="Lai W">W Lai</name></author><author><name sortKey="Sheng, F" uniqKey="Sheng F">F Sheng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Montessuit, S" uniqKey="Montessuit S">S Montessuit</name></author><author><name sortKey="Somasekharan, Sp" uniqKey="Somasekharan S">SP Somasekharan</name></author><author><name sortKey="Terrones, O" uniqKey="Terrones O">O Terrones</name></author><author><name sortKey="Lucken Ardjomande, S" uniqKey="Lucken Ardjomande S">S Lucken-Ardjomande</name></author><author><name sortKey="Herzig, S" uniqKey="Herzig S">S Herzig</name></author><author><name sortKey="Schwarzenbacher, R" uniqKey="Schwarzenbacher R">R Schwarzenbacher</name></author><author><name sortKey="Manstein, Dj" uniqKey="Manstein D">DJ Manstein</name></author><author><name sortKey="Bossy Wetzel, E" uniqKey="Bossy Wetzel E">E Bossy-Wetzel</name></author><author><name sortKey="Basanez, G" uniqKey="Basanez G">G Basanez</name></author><author><name sortKey="Meda, P" uniqKey="Meda P">P Meda</name></author><author><name sortKey="Martinou, Jc" uniqKey="Martinou J">JC Martinou</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Yy" uniqKey="Wang Y">YY Wang</name></author><author><name sortKey="Zhao, R" uniqKey="Zhao R">R Zhao</name></author><author><name sortKey="Zhe, H" uniqKey="Zhe H">H Zhe</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mattiazzi, A" uniqKey="Mattiazzi A">A Mattiazzi</name></author><author><name sortKey="Bassani, Ra" uniqKey="Bassani R">RA Bassani</name></author><author><name sortKey="Escobar, Al" uniqKey="Escobar A">AL Escobar</name></author><author><name sortKey="Palomeque, J" uniqKey="Palomeque J">J Palomeque</name></author><author><name sortKey="Valverde, Ca" uniqKey="Valverde C">CA Valverde</name></author><author><name sortKey="Vila Petroff, M" uniqKey="Vila Petroff M">M Vila Petroff</name></author><author><name sortKey="Bers, Dm" uniqKey="Bers D">DM Bers</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Luczak, Ed" uniqKey="Luczak E">ED Luczak</name></author><author><name sortKey="Anderson, Me" uniqKey="Anderson M">ME Anderson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhu, Lj" uniqKey="Zhu L">LJ Zhu</name></author><author><name sortKey="Klutho, Pj" uniqKey="Klutho P">PJ Klutho</name></author><author><name sortKey="Scott, Ja" uniqKey="Scott J">JA Scott</name></author><author><name sortKey="Xie, L" uniqKey="Xie L">L Xie</name></author><author><name sortKey="Luczak, Ed" uniqKey="Luczak E">ED Luczak</name></author><author><name sortKey="Dibbern, Me" uniqKey="Dibbern M">ME Dibbern</name></author><author><name sortKey="Prasad, Am" uniqKey="Prasad A">AM Prasad</name></author><author><name sortKey="Jaffer, Oa" uniqKey="Jaffer O">OA Jaffer</name></author><author><name sortKey="Venema, An" uniqKey="Venema A">AN Venema</name></author><author><name sortKey="Nguyen, Ek" uniqKey="Nguyen E">EK Nguyen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dilshara, Mg" uniqKey="Dilshara M">MG Dilshara</name></author><author><name sortKey="Jayasooriya, R" uniqKey="Jayasooriya R">R Jayasooriya</name></author><author><name sortKey="Molagoda, Imn" uniqKey="Molagoda I">IMN Molagoda</name></author><author><name sortKey="Jeong, Jw" uniqKey="Jeong J">JW Jeong</name></author><author><name sortKey="Lee, S" uniqKey="Lee S">S Lee</name></author><author><name sortKey="Park, Sr" uniqKey="Park S">SR Park</name></author><author><name sortKey="Kim, Gy" uniqKey="Kim G">GY Kim</name></author><author><name sortKey="Choi, Yh" uniqKey="Choi Y">YH Choi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Toledo, Fd" uniqKey="Toledo F">FD Toledo</name></author><author><name sortKey="Perez, Lm" uniqKey="Perez L">LM Perez</name></author><author><name sortKey="Basiglio, Cl" uniqKey="Basiglio C">CL Basiglio</name></author><author><name sortKey="Ochoa, Je" uniqKey="Ochoa J">JE Ochoa</name></author><author><name sortKey="Sanchez Pozzi, Ej" uniqKey="Sanchez Pozzi E">EJ Sanchez Pozzi</name></author><author><name sortKey="Roma, Mg" uniqKey="Roma M">MG Roma</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Xie, R" uniqKey="Xie R">R Xie</name></author><author><name sortKey="Gao, Cc" uniqKey="Gao C">CC Gao</name></author><author><name sortKey="Yang, Xz" uniqKey="Yang X">XZ Yang</name></author><author><name sortKey="Wu, Sn" uniqKey="Wu S">SN Wu</name></author><author><name sortKey="Wang, Hg" uniqKey="Wang H">HG Wang</name></author><author><name sortKey="Zhang, Jl" uniqKey="Zhang J">JL Zhang</name></author><author><name sortKey="Yan, W" uniqKey="Yan W">W Yan</name></author><author><name sortKey="Ma, Th" uniqKey="Ma T">TH Ma</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Clin Cancer Res</journal-id><journal-id journal-id-type="iso-abbrev">J. Exp. Clin. Cancer Res</journal-id><journal-title-group><journal-title>Journal of Experimental & Clinical Cancer Research : CR</journal-title></journal-title-group><issn pub-type="ppub">0392-9078</issn><issn pub-type="epub">1756-9966</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31138329</article-id><article-id pub-id-type="pmc">6540563</article-id><article-id pub-id-type="publisher-id">1201</article-id><article-id pub-id-type="doi">10.1186/s13046-019-1201-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hu</surname><given-names>Jinjiao</given-names></name><address><email>13896194028@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Yanhao</given-names></name><address><email>406339261@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Xiuxing</given-names></name><address><email>1119862476@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Hongwei</given-names></name><address><email>zhwqz@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Ziyi</given-names></name><address><email>ziyi.gao13@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yunong</given-names></name><address><email>lyn90911@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Ruoqiu</given-names></name><address><email>zxmfrq@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Lirong</given-names></name><address><email>598625482@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jie</given-names></name><address><email>550884945@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cui</surname><given-names>Hongjuan</given-names></name><address><email>hongjuan.cui@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gao</surname><given-names>Ning</given-names></name><address><email>gaoning59@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>College of Pharmacy, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing, 400038 China</aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0240 6969</institution-id><institution-id institution-id-type="GRID">grid.417409.f</institution-id><institution>Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education,</institution><institution>Zunyi Medical University,</institution></institution-wrap>Zunyi, China</aff><aff id="Aff3"><label>3</label>Greater Philadelphia Pharmacy, Philadelphia, USA</aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.263906.8</institution-id><institution>State Key Laboratory of Silkworm Genome Biology,</institution><institution>Southwest University,</institution></institution-wrap>2#Tiansheng Road, Beibei District, Chongqing, 400716 China</aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.263906.8</institution-id><institution>Medical Research Institute, Southwest University,</institution></institution-wrap>2#Tiansheng Road, Beibei District, Chongqing, 400716 China</aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>38</volume><elocation-id>225</elocation-id><history><date date-type="received"><day>18</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Triple-negative breast cancer (TNBC) is often aggressive and associated with a poor prognosis. Due to the lack of available targeted therapies and to problems of resistance with conventional chemotherapeutic agents, finding new treatments for TNBC remains a challenge and a better therapeutic strategy is urgently required.</p></sec><sec><title>Methods</title><p id="Par2">TNBC cells and xenograft mice were treated with a combination of chloroquine (CQ) and isorhamnetin (IH). Mitochondrial fission, apoptosis, and related signaling pathways were determined by flow cytometry, immunofluorescence, and related molecular biological techniques.</p></sec><sec><title>Results</title><p id="Par3">The inhibition of autophagy/mitophagy by CQ selectively enhances IH-induced mitochondrial fission and apoptosis in TNBC cells but not in estrogen-dependent breast cancer cells. These events were accompanied by mitochondrial translocation of Bax and the release of cytochrome c. Mechanistically, these effects were associated with oxidative stress-mediated phosphorylation of CaMKII (Thr286) and Drp1 (S616), and subsequent mitochondrial translocation of CaMKII and Drp1. The interruption of the CaMKII pathway by genetic approaches (e.g. CaMKII mutant or siRNA) attenuated combination-mediated mitochondrial fission and apoptosis. The combination of CQ/IH was a marked inhibitor tumor growth, inducing apoptosis in the TNBC xenograft mouse model in association with the activation of CaMKII and Drp1 (S616).</p></sec><sec><title>Conclusions</title><p id="Par4">Our study highlights the critical role of ROS-mediating CaMKII/Drp1 signaling in the regulation of mitochondrial fission and apoptosis induced by combination of CQ/IH. These findings also suggest that IH could potentially be further developed as a novel chemotherapeutic agent. Furthermore, a combination of IH with classic autophagy/mitophagy inhibitor could represent a novel therapeutic strategy for the treatment of TNBC.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13046-019-1201-4) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Triple-negative breast cancer</kwd><kwd>Chloroquine</kwd><kwd>Isorhamnetin</kwd><kwd>Autophagy</kwd><kwd>Apoptosis</kwd><kwd>CaMKII</kwd><kwd>Drp1</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Natural Science Foundation of China </institution></funding-source><award-id>31571425, 81402970; 81402013</award-id><principal-award-recipient><name><surname>Gao</surname><given-names>Ning</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par11">Breast cancer is the most common malignancy and is a leading cause of cancer-related deaths in women worldwide [<xref ref-type="bibr" rid="CR1">1</xref>]. Among its different subtypes, triple-negative breast cancer (TNBC) accounts for 15–20% of diagnosed breast tumors, there being a higher incidence in young and African-American women [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. TNBC constitutes a heterogeneous group of malignancies that are often aggressive and associated with a poor prognosis [<xref ref-type="bibr" rid="CR4">4</xref>]. Due to a lack of available targeted therapies and to problems of resistance to conventional chemotherapeutic agents, finding new treatments for TNBC remains a challenge; a better therapeutic strategy is urgently required [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par12">Autophagy is a mechanism by which cellular material is delivered to lysosomes for degradation [<xref ref-type="bibr" rid="CR7">7</xref>]. Autophagy acts as pro-survival pathway in cancer cells by promoting the viability and growth of these cells and imparts resistance in them to many chemotherapeutic agents in tumor cells, including TNBC cells [<xref ref-type="bibr" rid="CR8">8</xref>]. Therefore, autophagy inhibition has been regarded as a promising therapeutic approach in the treatment of TNBC and other cancers. Recent evidence reveals that the inhibition of autophagy has been identified as a potential adjunctive strategy for enhancing the chemotherapeutic effect [<xref ref-type="bibr" rid="CR9">9</xref>]. The antimalaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ) are currently the only clinically-available drugs that inhibit autophagy. Extensive preclinical evidence reveals that the inhibition of autophagy by CQ or HCQ increases the potential of anticancer chemotherapeutic agents such as the antiretroviral Nelfinavir and the COX2 inhibitor Celecoxib in TNBC [<xref ref-type="bibr" rid="CR10">10</xref>]. The current study reveals that the inhibition of autophagy by CQ could enhance the effects of chemotherapeutic agents in treating TNBC patients with high LC3B protein levels [<xref ref-type="bibr" rid="CR11">11</xref>]. Owing to the limitations of current chemotherapeutic agents in the treatment of TNBC, it is important to develop novel and efficacious chemotherapeutic agents that target TNBCs.</p><p id="Par13">Isorhamnetin (IH), also called 3-O-methylquercetin (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a), is a flavonoid that is present in plants of the <italic>Polygonaceae</italic> family; it is also an immediate metabolite of quercetin in mammals [<xref ref-type="bibr" rid="CR12">12</xref>]. IH has received attention due to its antitumor properties in cancers such as lung, esophageal, gastric, colorectal, skin, and breast cancers [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. IH has displayed a diversity of anti-tumor activities, including inhibiting migration and invasion, inhibiting cell proliferation, and the induction of apoptosis through various signaling pathways (e.g. p38/STAT3, MEK, Akt/mTOR). It has recently been shown that IH induces autophagy in human breast cancer cells through modulating the PI3K/AKT/mTOR/p70S6K/ULK signaling pathway [<xref ref-type="bibr" rid="CR19">19</xref>]. Yuan Y, et al. reported that the inhibition of autophagy by CQ enhances IH-induced mitochondria-dependent apoptosis in non-small lung cancer cells. However, the precise mechanism by which the inhibition of autophagy potentiates IH-induced mitochondrial apoptosis in breast cancer cells remains unclear.<fig id="Fig1"><label>Fig. 1</label><caption><p>CQ dramatically potentiates IH-mediated inhibition of cell proliferation and the induction of apoptosis in TNBC cells. <bold>a</bold> The chemical structure of isorhamnetin (IH). <bold>b</bold> and <bold>c</bold> MDA-MB-231, BT549, MCF-7, and MCF-10A cells were treated with various concentrations of IH in the presence or absence of 20 μM CQ for 48 h, and MTT assays were performed to assess cell proliferation—mean ± SD for three independent experiments, ns, not significant, <sup>*</sup><italic>P</italic> < 0.05, <sup>**</sup><italic>P</italic> < 0.01 or <sup>***</sup><italic>P</italic> < 0.001 compared with IH. <bold>d</bold> The combination index (CI) values for each fraction affected were determined using commercially-available software (Calcusyn, Biosoft). CI values less than 1.0 correspond to synergistic interactions. <bold>e</bold> and <bold>f</bold> Colony formation was detected using a soft agar assay in MDA-MB-231 and BT549 cells (mean ± SD for three independent experiments, <sup>***</sup><italic>P</italic> < 0.001 compared with control). <bold>g</bold>-<bold>i</bold> MDA-MB-231 cells were combination treated with CQ (20 μM) and IH (10 μM) for 48 h. Apoptosis was determined by Annexin V-FITC/PI staining and flow cytometry (mean ± SD for 3 independent experiments; <sup>***</sup><italic>P</italic> < 0.001 compared with control or CQ and IH treatment alone). The total cellular extract, cytosol and mitochondrial fractions were prepared and subjected to western blot using antibodies against total PRAP, C-PARP, pro-Caspase 3, cleaved caspase-3, cytochrome c (Cyto C), Bak, and Bax. β-actin and COX IV were used as loading controls</p></caption><graphic xlink:href="13046_2019_1201_Fig1_HTML" id="MO1"></graphic></fig></p><p id="Par14">In this study, we discovered that the inhibition of autophagy/mitophagy by CQ selectively enhances IH-induced mitochondrial fission and apoptosis in TNBC cells but not in estrogen-dependent breast cancer cells. Mechanistically, this effect is mediated by oxidative stress-phosphorylated Ca<sup>2+</sup>/calmodulin-dependent kinase II (CaMKII) (Thr286) and Drp1 (S616) and, subsequently, their mitochondrial translocation. Our data identify autophagy as a novel prognostic marker for TNBC: a combination of IH with CQ could represent a novel therapeutic strategy for treating TNBC.</p></sec><sec id="Sec2"><title>Material and methods</title><sec id="Sec3"><title>Chemicals and antibodies</title><p id="Par15">Isorhamnetin was purchased from Must Biotechnology (Chengdu, China); chloroquine from Sigma-Aldrich; Mn-TBAP from Focus Biomolecules; apocynin was purchased from Selleck Chemicals (Shanghai, CA). The antibodies against cleaved-caspase 3 (9661), pro-caspase 3 (9668S), p62 (5114S), phospho-CamkII (T286, 12,716), phospho-Drp1 (S616, 3455), phospho-Drp1 (S637, 4876), and Drp1 (8570) were purchased from Cell Signaling Technology; PARP (1078–1) was purchased from Epitomics; β-actin (A1978) and LC3 (L754S) from Sigma-Aldrich; Bax (510804), Cleaved-PARP (380374), Bak (380976), NOX2 (381293), NOX4 (380874) and COX IV (200147) from Zen-Bio. Cytochrome. C (13156) and CamkII (5306) were purchased Santa Cruz Biotechnology.</p></sec><sec id="Sec4"><title>Cell culture</title><p id="Par16">MDA-MB-231 and MCF-7 cells were cultured in DMEM medium; BT549 cells in RPMI 1640 medium; MCF-10A in MEBM medium. All media comprised 10% fetal bovine serum (FBS) and antibiotics. All cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA) and cultured at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>.</p></sec><sec id="Sec5"><title>Cell viability (MTT) assay</title><p id="Par17">Cells were seeded in 96 well plates (3.5 × 10<sup>3</sup> per each well). After treatment, 20 μl MTT (5 mg/ml) was added in each well and incubated at 37 °C for 4 h. After the medium was discarded, each well was supplemented with 150 μl DMSO to dissolve the formazan before being measured by a microplate reader at 490 nm. The cell viabilities were normalized to the control group.</p></sec><sec id="Sec6"><title>Soft agar assay</title><p id="Par18">Sustainment gel was mixed with 0.6% agarose (Sigma-Aldrich) in a cell culture medium in 12 well plates. One-thousand cells were cultured in cultivate gel above concretionary sustainment gel (mixed with 0.3% agarose in cell culture medium with 10% FBS). After 28 days, the colonies were counted and photographed.</p></sec><sec id="Sec7"><title>Apoptosis assay</title><p id="Par19">Apoptosis was examined by flow cytometry according to the manufacturer’s instructions (BD Biosciences PharMingen). In summary, 1 × 10<sup>6</sup> cells were washed twice with phosphate-buffered saline (PBS) and stained with 5 μl Annexin V-FITC and 10 μl PI for 15 min at room temperature in the dark. Quantification of apoptotic cells was performed by flow cytometry using a FACScan cytofluorometer (BD Biosciences). Both early (Annexin V-positive, PI-negative) and late (Annexin V-positive and PI-positive) apoptotic cells were included in the cell death determinations.</p></sec><sec id="Sec8"><title>Mitochondrial and cytosolic fractionation</title><p id="Par20">Mitochondrial and cytosolic fractionation were obtained as previously described [<xref ref-type="bibr" rid="CR20">20</xref>]. In summary, cell pellets were washed twice with PBS and resuspended in 5 × Buffer A (20 mM HEPES, 10 mM KCl, 1.5 mM MgCl<sub>2</sub>, 1 mM EDTA, 1 mM EGTA, 1 mM Na<sub>3</sub>VO<sub>4</sub>). Cells were homogenized by passing them 15 times through a 22-gauge needle. The homogenate was centrifuged at 1000 g at 4 °C for 10 min. The supernatant was then transferred and continued being centrifuged at 3500 g at 4 °C for 10 min. The pellet fraction was considered the “mitochondrial” fraction. The supernatant fraction was then centrifuged at 120000 g at 4 °C for 10 min; the supernatant fraction was then considered the “cytosolic” fraction.</p></sec><sec id="Sec9"><title>Western blot and immunoprecipitation</title><p id="Par21">The protein samples (30–50 μg) were separated using SDS-PAGE and transferred to PVDF membranes (Bio-Rad, 162–0177). After blocking with 5% fat-free dry milk in 1 × Tris-buffered saline (TBS), the membrane was probed overnight with primary antibodies at 4 °C. Protein bands were detected by incubating with horseradish peroxidase-conjugated antibodies (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) and visualized with enhanced chemiluminescence reagent (Perkin-Elmer, Boston, MA, USA). For immunoprecipitation analysis, equal quantities of proteins were incubated with primary antibodies at 4 °C on a rocking platform. Immune complexes were collected with protein A/G agarose beads (Beyotime Technology), washed in PBS five times, and subjected to Western blot.</p></sec><sec id="Sec10"><title>Detection of calcium ion level</title><p id="Par22">The Ca<sup>2+</sup> level was determined by using the fluorescent dye Fluo-4/AM (Invitrogen). Briefly, cells were washed three times with HBSS, then incubated with 4 μM Fluo-4/AM (diluted with HBSS) at 37 °C for 30 min. After being washed twice with HBSS, followed by an additional 15-min incubation at 37 °C to allow complete de-esterification of intracellular AM esters, the cells were detected by flow cytometry using a FACScan cytofluorometer (BD Biosciences).</p></sec><sec id="Sec11"><title>Immunofluorescence</title><p id="Par23">Cells were seeded on coverslips and cultured in 24 well plates for 24 h. After treatment for 24 h, mitochondria were stained with MitoTracker Deep Red FM (Molecular Probes, Carlsbad, USA) according to the manufacturer’s instructions. Cells were fixed with 4% formaldehyde (Beyotime Biotechnology) for 30 min, permeabilized with 0.1% Triton X-100 in PBS for 5 min, and then blocked with goat serum (Beyotime Biotechnology) in PBS for 30 min. The cells were incubated overnight with primary antibodies at 4 °C, followed by the appropriate secondary antibodies at 37 °C for 1 h. The cells were viewed using a laser-scanning confocal microscope (Zeiss, Germany). All images were analyzed by ImageJ software (MD, USA).</p></sec><sec id="Sec12"><title>Detection of intracellular ROS</title><p id="Par24">Intracellular production of ROS was measured using DCFH-DA. To determine ROS production, cells were incubated with DCFH-DA (10 μM) for 30 min, washed twice with cold PBS and detected by flow cytometry using a FACScan cytofluorometer (BD Biosciences).</p></sec><sec id="Sec13"><title>RNA interference and site mutant</title><p id="Par25">The target sequence of CamkII shRNA (5′-CGTAAATGGATTTCGCGTTAA-3′) was constructed by Gene Chem Co. Ltd. (Shanghai, China). To generate CamkII knockdown stable cell lines, a lentiviral system was employed as previously described [<xref ref-type="bibr" rid="CR21">21</xref>]. Briefly, 293FT cells were co-transfected with lentiviral packing vectors pLP1, pLP2 and pLP/VSVG (Invitrogen), along with shCamkII or shCon plasmid, using Lipofectamine 3000 (Invitrogen) for 48 h. The supernatant containing the lentivirus was harvested and used for infection with MDA-MB-231 cells. The cells were subsequently selected with 8 μg/mL puromycin to establish stable cell lines. Site mutant plasmids of CamkII (CamkII<sup>T286A</sup> and CamkII<sup>T286D</sup>) were constructed by Gene Chem Co. Ltd. (Shanghai, China). The sequence of primers for CamkII<sup>T286A</sup> were forward 5′-CACAGACAGGAGGCCGTGGACTGCCTG-3′, and reverse 3′-GTGTCTGTCCTCCGGCACCTGACGGAC-5′. Primers for CamkII<sup>T286D</sup> were forward 5′-CACAGACAGGAGGATGTGGACTGCCTG-3′, and reverse 3′-GTGTCTGTCCTCCTACACCTGACGGAC-5′. MDA-MB-231 cells were transfected with CamkII<sup>T286A</sup> and CamkII<sup>T286D</sup> using Lipofectamine 3000 according to the manufacturer’s instructions.</p></sec><sec id="Sec14"><title>Xenograft assay</title><p id="Par26">Female nude mice (5–6 weeks old) were purchased from Vital River Laboratories (VRL, Beijing, China) and fed a standard animal diet and water. The animal studies were approved by the University Institutional Animal Care and Use Committee. MDA-MB-231 cells were suspended in a 1:1 ratio in DMEM medium with a Matrigel basement membrane matrix (Sigma, E1270). Cells (4 × 10<sup>7</sup>) were inoculated in the right legs of mice. After tumor inoculation, the mice were randomly divided into four treatment groups (16 mice per group; six mice were used for body weight and tumor volume measurement, the others for survival analysis). The mice were treated with either vehicle, CQ (40 mg/kg) or IH (20 mg/kg), or a combination of CQ/IH by intraperitoneal injection once every 2 days. The body weight and tumor volume (mm<sup>3</sup>) were measured. The mice were euthanized 30 days after medication, the tumors were excised and were either formalin-fixed or flash-frozen at − 20 °C. H&E, TUNEL, and immunohistochemical analyses were performed as previously described [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec15"><title>Statistical analysis</title><p id="Par27">All data values are represented as mean ± SD. The comparisons were performed using Student’s t-test or one-way analysis of variance (ANOVA). Survival analysis in vivo was performed using the Kaplan–Meier method and significance was calculated using the log-rank test. <sup>*</sup><italic>P</italic> < 0.05, <sup>**</sup><italic>P</italic> < 0.01, and <sup>***</sup><italic>P</italic> < 0.001 were regarded as significant differences.</p></sec></sec><sec id="Sec16"><title>Results</title><sec id="Sec17"><title>Chloroquine dramatically potentiates isorhamnetin-mediated inhibition of cell proliferation and induction of apoptosis in triple negative breast cancer cells</title><p id="Par28">The effects of combined treatment with CQ and IH on cell viability were first investigated in multiple human breast cancer cell lines. Exposure to a subtoxic concentration of CQ (20 μM) significantly decreased the cell viability in both triple negative breast cancer MDA-MB-231 and BT549 cells treated with a nontoxic concentration of IH (2.5 μM), and the degree of potentiation increased as concentrations increased (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). In contrast, CQ in combination with IH exerted little effect on cell viability toward MCF-7 (estrogen-dependent) cells (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b) and normal breast epithelial MCF-10A cells (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c). The median dose effect analysis of cell viability in cells exposed to CQ and IH for 48 h at fixed ratios yielded CI values consistently less than 1.0 in MDA-MB-231 and BT549 cells but greater than 1.0 in MCF-7 cells (Fig. <xref rid="Fig1" ref-type="fig">1</xref>d). We also examined the effects of CQ/IH on colony formation in both MDA-MB-231 and BT549 cells in vitro by using soft agar assay. As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>e and f, the combination of CQ/IH significantly decreased the number of colonies in MDA-MB-231 and BT549 cells. These results indicate that the combination of CQ/IH selectively inhibits cell proliferation and tumorigenesis in TNBC cells.</p><p id="Par29">We next investigated the synergistic effects of CQ/IH on apoptosis in MDA-MB-231 and BT549 cells. Combined treatment with minimally-toxic concentrations of CQ (20 μM) and IH (10 μm) resulted in a pronounced increase in apoptosis in MDA-MB-231 and BT549 cells (Fig. <xref rid="Fig1" ref-type="fig">1</xref>g and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1A). Consistent with these findings, the same CQ and IH concentrations resulted in a degradation of PARP, cleavage/activation of caspases-3 and release of cytochrome c into the cytosolic fraction (Figs. <xref rid="Fig1" ref-type="fig">1</xref>h and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1B). The translocation of Bax and Bak from the cytosol to the mitochondria was also noted in cells treated with a combination of CQ/IH (Fig. <xref rid="Fig1" ref-type="fig">1</xref>i and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1C). Together, these findings indicate that CQ interacts synergistically with IH to selectively induce mitochondrial injury and apoptosis in TNBC cells.</p></sec><sec id="Sec18"><title>Excessive accumulation of mitophagosomes contributes to mitochondrial injury and apoptosis mediated by a combination of CQ and IH</title><p id="Par30">Since CQ suppresses autophagic flux by blocking autophagosome-lysosome fusion, we subsequently investigated the effects of the combination of CQ/IH on the accumulation of mitophagosomes. As shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>a, treating cells with CQ alone resulted in the accumulation of LC3B-II and p62 in mitochondria. Treating cells with IH, an autophagy inducer [<xref ref-type="bibr" rid="CR19">19</xref>], resulted in modest increases in levels of LC3B-II and decreases in levels of p62 in mitochondria. Joint treatment with CQ/IH resulted in excessive accumulation of LC3B-II and p62 in mitochondria. Similarly, significant increases in colocalization of GFP-LC3 and RFP-Mito were observed in cells combined-treated with CQ/IH (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b), suggesting that excessive accumulation of mitophagosomes may be involved in mitochondrial injury and apoptosis in cells treated with a combination of CQ/IH. To test this possibility, a siRNA approach was used to stably knock down ATG5 expression (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c). Knockdown of ATG5 markedly reduced combination-mediated LC3B-II accumulation in mitochondria (Fig. <xref rid="Fig2" ref-type="fig">2</xref>d) and mitophagosome formation (Fig. <xref rid="Fig2" ref-type="fig">2</xref>e). Knockdown of ATG5 also abrogated combination-mediated degradation of PARP, cleavage/activation of caspase-3 and cytochrome c release (Fig. <xref rid="Fig2" ref-type="fig">2</xref>f), as well as apoptosis (Fig. <xref rid="Fig2" ref-type="fig">2</xref>g and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2). Together, these findings indicate that the excessive accumulation of mitophagosomes is implicated in mitochondrial injury and apoptosis mediated by the combination of CQ/IH in TNBC cells.<fig id="Fig2"><label>Fig. 2</label><caption><p>Excessive accumulation of mitophagosomes contributes to apoptosis induced by CQ/IH combination. <bold>a</bold> MDA-MB-231 cells were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 48 h, after which the mitochondrial fractions were prepared and subjected to Western blot analysis using antibodies against p62, LC3-I/LC3-II. <bold>b</bold> Cells expressed with EGFP-LC3 were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 48 h. The colocalization of EGFP-LC3 and MitoTracker (Deep Red FM) was examined using confocal microscopy. Scale bars: 10 μm. <bold>c</bold> Cells were transfected with control shRNA (shControl) or shATG5, and Western blot analysis was used to determine the expression of ATG5. For <bold>d</bold>-<bold>g</bold>, cells stably expressing shControl or shATG5 were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 48 h. <bold>d</bold> The mitochondrial fractions were prepared and subjected to Western blot using antibodies against LC3-I/LC3-II. <bold>e</bold> The colocalization of EGFP-LC3 and MitoTracker (Deep Red FM) was examined by confocal microscopy. Scale bars: 10 μm. <bold>f</bold> The expressions of total PRAP, C-PARP, pro-Caspase 3, C-Caspase 3 and Cyto C (Cytosolic fraction) were determined by Western blot. <bold>g</bold> Apoptosis was detected by flow cytometry analysis. The values obtained from the Annexin V/PI assay represent the mean ± SD for three separate experiments. <sup>***</sup>Values for cells combination-treated with CQ/IH after transfection with shATG5 are significantly decreased compared with those in shControl cells combined treated with CQ/IH, <sup>***</sup><italic>P</italic> < 0.001</p></caption><graphic xlink:href="13046_2019_1201_Fig2_HTML" id="MO2"></graphic></fig></p></sec><sec id="Sec19"><title>The combination of CQ/IH induces mitochondrial fission through phosphorylation of CamkII (Thr286) and Drp1 (Ser616) and their mitochondrial translocation</title><p id="Par31">Recent studies indicate that mitochondrial fission participates in Bax-mediated permeabilization of the outer mitochondrial membrane and cytochrome c release [<xref ref-type="bibr" rid="CR23">23</xref>]. Therefore, we next examined the effects of the combination of CQ/IH on mitochondrial dynamics using MitoTracker Red CMXRos. The combination of CQ/IH resulted in a significant increase in the proportion of cells with fragmented mitochondria (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a and b, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3A and S3B).<fig id="Fig3"><label>Fig. 3</label><caption><p>Combination of CQ/IH induces phosphorylation and mitochondrial translocation of CaMKII (Thr286) and Drp1 (Ser616). MDA-MB-231 cells were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 48 h. <bold>a</bold> Mitochondrial morphology was observed by MitoTracker Red CMXRos staining and confocal microscopy. Scale bars: 10 μm. <bold>b</bold> Mitochondrial length was measured with ImageJ software. 50 cells from three independent experiments (mean ± SD, <sup>***</sup><italic>P</italic> < 0.001 compared with control). <bold>c</bold> Whole cellular lysates (WCL) and cytosolic (Cyto)/mitochondrial (Mito) fractions were prepared and subjected to Western blot using antibodies against phospho-Drp1 (p-Drp1) (S616), p-Drp1 (S637), and Drp1. <bold>d</bold> The colocalization of Drp1 (green) and MitoTracker (red) was examined using confocal microscopy. Scale bars: 10 μm. <bold>e</bold> The expression of p-CaMKII and CaMKII in WCL, Cyto, or Mito was examined by Western blot. <bold>f</bold> The colocalization of CaMKII (green) and MitoTracker (red) was examined by confocal microscopy. Scale bars: 10 μm. <bold>g</bold> and <bold>h</bold> The calcium ion level was analyzed by flow cytometry. The values represent the mean ± SD for three separate experiments (<sup>***</sup><italic>P</italic> < 0.001 compared with control). <bold>i</bold> Whole cell lysates were prepared and subjected to immunoprecipitation using anti-CaMKII; the associated CaMKII and Drp1 were determined using immunoblotting. <bold>j</bold> The colocalization of CaMKII (red), Drp1 (green), and MitoTracker (blue) was examined using confocal microscopy. Scale bars: 10 μm</p></caption><graphic xlink:href="13046_2019_1201_Fig3_HTML" id="MO3"></graphic></fig></p><p id="Par32">Increasing evidence reveals that phosphorylation of Drp1 (Ser 616) or dephosphorylation of Drp1 (Ser 637) plays a critical role in the regulation of mitochondrial fission through its mitochondrial translocation [<xref ref-type="bibr" rid="CR24">24</xref>]. We then examined the effects of the combination of CQ/IH on the phosphorylation of Drp1 at Ser637 and Ser616, and the mitochondrial translocation of Drp1. Combined treatment with CQ/IH increased levels of phospho-Drp1 (Ser 616) but had no effect on the phosphorylation of Drp1 at Ser 637 (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3C). The combination of CQ/IH also led to the mitochondrial translocation of Drp1 (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3C). Immunofluorescence analysis showed the Drp1 signal in the mitochondria of cells treated with a combination of CQ/IH (Fig. <xref rid="Fig3" ref-type="fig">3</xref>d, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3D). Since the colocalization of Drp1 and Bax at the mitochondrial fission site is required for mitochondrial fission and apoptosis [<xref ref-type="bibr" rid="CR25">25</xref>], we next examined the effect of a combination of CQ/IH on the colocalization of Drp1 and Bax in mitochondria by using immunofluorescence analysis. The colocalization of Drp1 and Bax in mitochondria was observed in cells treated with a CQ/IH combination (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S4). These results support the proposition that the phosphorylation of Drp1 at the S616 site promotes its mitochondrial translocation, leading to mitochondrial fission and apoptosis through the colocalization of Drp1 and Bax in response to a combination of CQ/IH.</p><p id="Par33">Recent evidence reveals that the phosphorylation of Drp1 at S616 site promotes its mitochondrial translocation upon activation by Ca<sup>2+</sup>/calmodulin-dependent kinase II (CaMKII) [<xref ref-type="bibr" rid="CR26">26</xref>]. We next examined the effects of the CQ/IH combination on the phosphorylation of CaMKII (Thr286). Exposure to the CQ/IH combination resulted in marked increases in levels of phosphor-CaMKII (Thr286). However, this increase was not present when the agents were administered individually (Fig. <xref rid="Fig3" ref-type="fig">3</xref>e, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5A). Interestingly, combined treatment with CQ/IH led to a decrease in the levels of CaMKII in cytosol and increased levels of CaMKII in mitochondria (Fig. <xref rid="Fig3" ref-type="fig">3</xref>e, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5A). Similarly, immunofluorescence analysis showed the CaMKII signal in the mitochondria in the cells that were treated with a combination of CQ/IH (Fig. <xref rid="Fig3" ref-type="fig">3</xref>f, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5B). Such findings suggest that the phosphorylation of CaMKII promotes its mitochondrial translocation in response to a combination of CQ/IH.</p><p id="Par34">Since CaMKII was regulated by calcium ions [<xref ref-type="bibr" rid="CR27">27</xref>], we next determined the levels of intracellular calcium ions by using the fluorescent calcium indicator Fluo-4/AM. As shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>g and h, the combination of CQ/IH significantly increased the levels of intracellular calcium ions in MDA-MB-231 cells.</p><p id="Par35">Since phosphorylation of Drp1 (S616) can be modulated by kinases/phosphatases including CaMKII, it is critical to determine whether CaMKII can directly bind Drp1. Immunoprecipitation analysis showed that combined treatment with CQ/IH resulted in increased interaction of CaMKII and Drp1 (Fig. <xref rid="Fig3" ref-type="fig">3</xref>i, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5C). Immunofluorescence analysis also showed the colocalization of MitoTracker with CaMKII and Drp1 in cells treated with a combination of CQ/IH (Fig. <xref rid="Fig3" ref-type="fig">3</xref>j, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5D). Taken together, these findings suggest that a combination of CQ/IH induces mitochondrial fission through the activation of CaMKII and its mitochondrial translocation, leading to the phosphorylation and mitochondrial translocation of Drp1.</p></sec><sec id="Sec20"><title>Genetic interruption of CaMKII abrogates mitochondrial fission and apoptosis induced by CQ/IH</title><p id="Par36">In order to further investigate the role of CaMKII phosphorylation at Thr286 in mitochondrial fission and apoptosis induced by the combination of CQ/IH, we generated a mutant of CaMKII<sup>T286A</sup> to occlude Thr286 phosphorylation or a mutant of CaMKII<sup>T286D</sup> to mimic Thr286 phosphorylation (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a). Overexpression of CaMKII<sup>T286A</sup> blocked the phosphorylation of CaMKII (Thr286)/Drp1 (S616) and the mitochondrial translocation of CaMKII/Drp1 in cells treated with a combination of CQ/IH. On the other hand, an overexpression of CaMKII<sup>T286D</sup> promoted the phosphorylation of CaMKII (Thr286)/Drp1 (S616) and the mitochondrial translocation of CaMKII/Drp1 in cells treated with either CQ or IH alone or a combination of these (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a). CaMKII<sup>T286A</sup> also blocked the colocalization of MitoTracker with CaMKII and Drp1 in cells treated with combination, whereas CaMKII<sup>T286D</sup> increased the colocalization of MitoTracker with CaMKII and Drp1 in cells treated with either CQ or IH alone or a combination of these (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b). Furthermore, CaMKII<sup>T286A</sup> attenuated mitochondrial fission, the mitochondrial translocation of Bax, the activation of caspase-3, the release of cytochrome c, and apoptosis induced by combination, whereas CaMKII<sup>T286D</sup> promoted these events mediated by either CQ or IH alone or their combination (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6A-S6D). Thus, our data indicate that the phosphorylation and mitochondrial translocation of CaMKII play critical roles in mitochondrial fission and apoptosis induced by a combination of CQ/IH.<fig id="Fig4"><label>Fig. 4</label><caption><p>Genetic interruption of CaMKII blocks mitochondrial fission and apoptosis induced by CQ/IH combination. MDA-MB-231 cells transfected with either wild type CaMKII (WT) or mutants CaMKII<sup>T286A</sup> (T286A) or CaMKII<sup>T286D</sup> (T286D) were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 48 h. <bold>a</bold> The expressions of p-CaMKII in WCL, and CaMKII and Drp1 in Mito were examined by Western blot. <bold>b</bold> The colocalization of CaMKII (red), Drp1 (green), and MitoTracker (blue) was examined by confocal microscopy. Scale bars: 10 μm. <bold>c</bold> Apoptosis was detected by flow cytometry analysis. The values represent the mean ± SD for three separate experiments (<sup>**</sup><italic>P</italic> < 0.01, <sup>***</sup><italic>P</italic> < 0.001). For <bold>d</bold>–<bold>f</bold>, cells transfected with either shControl or shCaMKII were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 24 h. <bold>d</bold> The expressions of p-CaMKII in WCL, and of CaMKII and Drp1 in Mito were examined by Western blot. <bold>e</bold> The colocalization of CaMKII (red), Drp1 (green), and MitoTracker (blue) was examined by confocal microscopy. Scale bars: 10 μm. <bold>f</bold> Apoptosis was detected by flow cytometry analysis. The values represent the mean ± SD for three separate experiments (<sup>**</sup><italic>P</italic> < 0.01)</p></caption><graphic xlink:href="13046_2019_1201_Fig4_HTML" id="MO4"></graphic></fig></p><p id="Par37">To further investigate the functional significance of CaMKII activation in CQ/IH-mediated mitochondrial fission and apoptosis, a siRNA approach was used to knock down CaMKII expression in a stable way (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7A). The knockdown of CaMKII blocked phosphorylation of CaMKII (T286)/Drp1 (S616) and mitochondrial translocation of CaMKII/Drp1 that was mediated by a combination of CQ/IH (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d). This knockdown of CaMKII also blocked the colocalization of MitoTracker with CaMKII and Drp1 in cells treated with the combination (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e). In addition, the knockdown of CaMKII blocked mitochondrial fission, the mitochondrial translocation of Bax, the activation of caspase-3, the release of cytochrome c, and apoptosis induced by combination (Fig. <xref rid="Fig4" ref-type="fig">4</xref>f, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7B-S7E). These results further identified the functional role of CaMKII in CQ/IH-mediated mitochondrial fission and apoptosis.</p></sec><sec id="Sec21"><title>Combined treatment with CQ/IH induces generation of reactive oxygen species</title><p id="Par38">Several types of evidence have demonstrated that activation of CaMKII is attributable to excessive production of reactive oxygen species (ROS) [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. We thus examined the effects of the CQ/IH combination on the generation of ROS in MDA-MB-231 and BT549 cells. By using flow cytometry analysis, we found that combined exposure of cells to CQ/IH resulted in significant increases in the generation of ROS (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8A). ROS—including superoxide radical (O<sub>2</sub><sup>•-</sup>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), and hydroxyl radical (OH•)—are recognized as signaling molecules that are mobilized in response to various stimuli [<xref ref-type="bibr" rid="CR30">30</xref>]. To explore further the role of individual ROS on combination-mediated mitochondrial fission and apoptosis, we employed three antioxidants—TBAP (a cell permeable SOD mimetic), catalase, and sodium formate—which primarily act on O<sub>2</sub><sup>•-</sup>, H<sub>2</sub>O<sub>2</sub>, and OH•, respectively. Pretreatment with TBAP, an O<sub>2</sub><sup>•-</sup> scavenger, abrogated combination-mediated ROS generation in both MDA-MB-231 and BT549 cells. In contrast, catalase (a H<sub>2</sub>O<sub>2</sub> scavenger) and sodium formate (an OH• scavenger) failed to block combination-mediated ROS generation in these cells (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8B). Attempts were then made to assess the functional significance of ROS in combination-induced mitochondrial fission and apoptosis. The addition of TBAP (but not of catalase and sodium formate) essentially abrogated the combination-mediated phosphorylation of CaMKII (T286)/Drp1 (S616) and the mitochondrial translocation of CaMKII/Drp1 (Fig. <xref rid="Fig5" ref-type="fig">5</xref>c). Pretreatment with TBAP also abrogated combination-mediated colocalization of MitoTracker with CaMKII and Drp1 (Fig. <xref rid="Fig5" ref-type="fig">5</xref>d). Furthermore, the addition of TBAP markedly abrogated combination-induced mitochondrial fission (Fig. <xref rid="Fig5" ref-type="fig">5</xref>e and f). Finally, the addition of TBAP significantly abrogated the combination-mediated mitochondrial translocation of Bax and Bak, the degradation of PARP, the activation of caspase 3, the release of cytochrome c, and apoptosis (Fig. <xref rid="Fig5" ref-type="fig">5</xref>g and h, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8C). Collectively, these finding suggest that ROS, particularly O<sub>2</sub><sup>•-</sup> radical, are primarily responsible for combination-induced mitochondrial fission and apoptosis through perturbations in CaMKII/Drp1 signaling events.<fig id="Fig5"><label>Fig. 5</label><caption><p>Effects of antioxidants on CQ/IH-induced ROS generation, mitochondrial fission, apoptosis, and cell signaling proteins. <bold>a</bold> MDA-MB-231 cells were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 6 h. Cells were stained with DCFHDA, and ROS production was analyzed by flow cytometry as described in Materials and Methods (mean ± SD for three independent experiments; <sup>***</sup><italic>P</italic> < 0.001 compared with control or CQ and IH treatment alone). <bold>b</bold> Cells were pretreated with antioxidants including TBAP (200 μM), catalase (5000 U/ml), and sodium formate (SF, 2 mM) for 1 h, followed by combined treatment with CQ/IH, after which ells were stained with DCFHDA; ROS production was then analyzed by flow cytometry (mean ± SD, <sup>***</sup><italic>P</italic> < 0.001). For C–H, cells were pretreated with TBAP, followed by the CQ/IH combination. <bold>c</bold> WCL and Mito were prepared and subjected to Western blot using antibodies against p-CaMKII (T286), p-Drp1 (S616), CaMKII, and Drp1. <bold>d</bold> The colocalization of CaMKII (red), Drp1 (green), and MitoTracker (blue) was examined by confocal microscopy. Scale bars: 10 μm. <bold>e</bold> Mitochondrial morphology was observed by MitoTracker Red CMXRos staining and confocal microscopy. Scale bars: 10 μm. <bold>f</bold> Mitochondrial length was measured with ImageJ software. Fifty cells of three independent experiments (mean ± SD, <sup>***</sup><italic>P</italic> < 0.001). <bold>g</bold> WCL, Cyto, and Mito were prepared and subjected to Western blot using antibodies against total PRAP, C-PARP, pro-Caspase 3, C-Caspase 3, cytochrome c, Bak, and Bax. <bold>h</bold> Apoptosis was detected by flow cytometry analysis. The values represent the mean ± SD for three separate experiments (mean ± SD, <sup>***</sup><italic>P</italic> < 0.001). <bold>i</bold> MDA-MB-231 cells were treated with CQ (20 μM) in the presence or absence of IH (10 μM) for 48 h. WCL were prepared and subjected to Western blot analysis using antibodies against NOX4 and NOX2, β-actin being used as a loading control. <bold>j</bold> Cells were pretreated with APO (100 μM) for 2 h, followed by the combination of CQ/IH. WCL were prepared and subjected to Western blot analysis using antibodies against NOX2, β-actin being used as a loading control. <bold>k</bold> and <bold>l</bold> Cells were pretreated with APO (100 μM) for 2 h, followed by the combination of CQ/IH for 6 h. Cells were stained with DCFHDA and ROS production was analyzed by flow cytometry. (mean ± SD for three independent experiments; <sup>***</sup><italic>P</italic> < 0.001)</p></caption><graphic xlink:href="13046_2019_1201_Fig5_HTML" id="MO5"></graphic></fig></p><p id="Par39">Increasing evidence indicates that NADPH oxidase (NOX) is a major source of superoxide anion radical (O<sub>2</sub><sup>•-</sup>) generation, and that NOX2 and NOX4 are key enzymes responsible for the oxidative burst [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Therefore, we next examined the effect of a combination of CQ/IH on the expression of NOX2 and NOX4. As shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>i, a CQ/IH combination increased the levels of NOX2 but had no effect on NOX4. In addition, pretreatment with apocynin, a selective NADPH oxidase inhibitor, abrogated combination-induced NOX2 expression and ROS generation (Fig. <xref rid="Fig5" ref-type="fig">5</xref>j, k and l).</p></sec><sec id="Sec22"><title>Inhibition of mitophagy enhances the inhibitory effect of IH on tumor growth in a TNBC xenograft mouse model in vivo</title><p id="Par40">To determine whether our in vitro findings that the inhibition of autophagy by CQ can be sensitized to IH-induced cell death could be replicated in vivo, we next examined the effect of CQ on the inhibitory efficacy of IH in vivo using a TNBC xenograft mouse model. After inoculation, mice received injections of either vehicle, CQ (40 mg/kg), IH (20 mg/kg) or a combination of these for 80 days. Kaplan–Meir survival analysis showed that the median survival time of the vehicle control group (<italic>n</italic> = 10) was approximately 34 days. Exposing mice only to CQ or IH resulted in mild increases in their survival time (36 or 39 days, <italic>n</italic> = 10). However, a combination of CQ/IH significantly improved the median survival of the mice to 62 days (<italic>P <</italic> 0.001 compared to the vehicle control) (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a). We next determined the effect of the CQ/IH combination on the tumor growth of the TNBC xenografts. CQ itself had no significant impact on tumor growth and IH treatment modestly inhibited tumor growth; however, a combination of CQ/IH caused greater inhibition of tumor growth (<italic>P <</italic> 0.001, compared to the vehicle control) (Fig. <xref rid="Fig6" ref-type="fig">6</xref>b). No statistically significant changes in body weight were noted in either vehicle control, CQ, IH, or the combination (Fig. <xref rid="Fig6" ref-type="fig">6</xref>c).<fig id="Fig6"><label>Fig. 6</label><caption><p>The combination of CQ/IH inhibits tumor growth in a TNBC xenograft mouse model. Sixty-four BALB/c nude mice were inoculated subcutaneously with MDA-MB-231 cells and randomly divided into four groups (16 mice per group, ten mice were used for determination of survival and six for determination of tumor volume and H&E, TUNEL, and immunohistochemistry analyses). After 5 days of inoculation<bold>,</bold> mice were treated with vehicle, CQ, IH, and the CQ/IH combination. <bold>a</bold> Comparison of the overall survival of mice between vehicle, CQ, IH and CQ/IH (<italic>n</italic> = 10 mice per group). Statistical significance in survival was determined by log-rank test. <sup>***</sup><italic>P</italic> < 0.01, comparison between vehicle and CQ/IH. <bold>b</bold> Average tumor volume in mice treated with vehicle, CQ, IH, and CQ/IH (<italic>n</italic> = 6 mice per group). <sup>***</sup><italic>P</italic> < 0.001, comparison between vehicle and CQ/IH. <bold>c</bold> Body weight of mice during the 30 days of treatment. <bold>d</bold> Tumor tissues were sectioned and subjected to H&E, TUNEL, and immunohistochemistry analyses for determination of morphology, apoptosis, and the expression of C-Caspase 3, p-CaMKII (T286), and p-Drp1 (S616). Original magnification × 200. Scale bars: 100 μm. <bold>e</bold> The proposed mechanism of the synergistic interactions between isorhamnetin and chloroquine</p></caption><graphic xlink:href="13046_2019_1201_Fig6_HTML" id="MO6"></graphic></fig></p><p id="Par41">We next examined the morphological changes, apoptosis, and CaMKII/Drp1 signaling pathway in the tumor tissue of the TNBC xenografts using H&E staining, TUNEL, and immunohistochemistry analyses. Whereas CQ itself had little effect on morphological changes and IH treatment led to modest decreases in the number of cancer cells, the combination of CQ/IH dramatically decreased the number of cancer cells and exhibited signs of the infiltration of inflammatory cells and apoptosis (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d, top panels). The TUNEL and immunohistochemistry analyses showed modest increases in apoptosis and cleaved caspase 3 in tumor sections of mice treated with IH alone, and a significant increase in apoptosis and cleaved caspase 3 in tumor sections of mice treated with CQ/IH (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d, second and third panels). Furthermore, combined treatment with CQ/IH led to significant increases in the interaction of CaMKII and Drp1 (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d, fourth panel). Taken together, these findings indicate a combination of CQ/IH inhibited tumor growth and induced apoptosis TNBC xenograft in vivo through interruption of CaMKII/Drp1 signaling.</p></sec></sec><sec id="Sec23"><title>Discussion</title><p id="Par42">In this study, we provide, for the first time, compelling evidence that inhibition of autophagy/mitophagy selectively potentiates IH-induced mitochondrial fission and apoptosis in TNBC cells. Increasing evidence reveals the close relationship between autophagy and apoptosis [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref>]. Inhibition of autophagy often causes excessive autophagy (e.g. increased amounts of both LC3-II and p62). This leads to autophagic stress, and ultimately, apoptosis [<xref ref-type="bibr" rid="CR33">33</xref>]. In the present study, we found that inhibition of autophagy by CQ potently enhanced IH-induced cell death. It is more likely that the excessive autophagosome accumulation could be involved in synergistic interactions between CQ and IH in mediating cell death based on the following observations. The first is that the combination of CQ and IH led to an increased accumulation of autophagosomes (e.g. increased amounts of both LC3-II and p62 in mitochondria and increased accumulation of mitophagosomes). Secondly, partially blocking autophagosome formation with siRNA against ATG5 markedly attenuated combination-mediated increased amounts of LC3-II in mitochondria and accumulation of mitophagosomes. The third was that the knockdown of ATG5 abrogated combination-induced PARP degradation, caspase-3 activation, cytochrome c release, and apoptosis. These findings suggest that the CQ/IH combination inducing cell death depends largely on excessive autophagy.</p><p id="Par43">In particular, we demonstrated the inhibition of autophagy/mitophagy by CQ-sensitized TNBC cells to IH-induced cell death through Drp1-dependent mitochondrial fission. Drp1 is a member of the conserved dynamin GTPase superfamily, which includes a broad range of membrane fission proteins [<xref ref-type="bibr" rid="CR36">36</xref>]. During mitochondrial fission, Drp1 is translocated from the cytosol to prospective fission sites on the mitochondria [<xref ref-type="bibr" rid="CR37">37</xref>]. Mitochondrial fission leads to cytochrome c release and the activation of caspases, which can ultimately lead to cell death [<xref ref-type="bibr" rid="CR38">38</xref>]. Drp1 is one of the main regulators of mitochondrial fission, and its recruitment to mitochondria is tightly regulated by posttranslational modifications such as phosphorylation, S-nitrosylation, SUMOylation, and ubiquitination [<xref ref-type="bibr" rid="CR39">39</xref>]. Among these modifications on Drp1, phosphorylation has been most extensively studied. Drp1-dependent mitochondrial fragmentation is controlled by phosphorylation at two different conserved sites, serine 616 and 637 [<xref ref-type="bibr" rid="CR40">40</xref>]. The two sites seem to have opposing effects on mitochondrial shape [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. While Drp1 phosphorylation at S616 promotes mitochondrial fission, Drp1 phosphorylation at S637 suppresses it [<xref ref-type="bibr" rid="CR24">24</xref>]. In this study, we demonstrate that the phosphorylation of Drp1 at S616 and its mitochondrial translocation are essential for mitochondrial fission and apoptosis mediated by the combination of CQ/IH based on multiple lines of evidence. The first is that the combination of CQ/IH led to phosphorylation of Drp1 at S616 but did not affect phosphorylation of Drp1 at S637. The second is that the combination of CQ/IH caused the mitochondrial translocation of Drp1. Our study also showed that the combination of CQ/IH caused the mitochondrial translocation of Bax. Increasing evidence reveals that, in response to apoptotic stimuli, mitochondrial translocation of Bax is essential for mitochondrial outer membrane permeabilization (MOMP) and the ensuing release of cytochrome c [<xref ref-type="bibr" rid="CR43">43</xref>]. Drp1 has previously been reported to be critical for cytochrome c release and apoptosis [<xref ref-type="bibr" rid="CR44">44</xref>]. A more likely possibility is that Drp1 might interact directly with activated Bax, creating a complex that is more active in MOMP, mitochondrial fission, and cytochrome c release [<xref ref-type="bibr" rid="CR45">45</xref>]. Consistent with this, our finding indicates that Drp1 is colocalized with Bax at mitochondrial fission sites during the combination of CQ/IH mediating cytochrome c release and apoptosis. Thus, these findings indicate that the phosphorylation of Drp1 (S616) and its mitochondrial translocation is critical for mitochondrial fission, cytochrome c release, and apoptosis in TNBC cells in response to the combination of CQ/IH.</p><p id="Par44">This study also provides evidence that the activation of calmodulin-dependent protein kinase II (CaMKII) is crucial to combination-induced mitochondrial fission and apoptosis in TNBC cells. CaMKII is a multifunctional serine/threonine protein kinase that plays an important role in the transmission of Ca<sup>2+</sup> signals to regulate various cellular processes [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. In a recent study, the activation of CaMKII and the subsequent phosphorylation of Drp1 at S616 are critical for mitochondrial fission during chronic β-adrenergic stimulation [<xref ref-type="bibr" rid="CR26">26</xref>]. It has also been demonstrated that CaMKII mediates radiation-induced mitochondrial fission by regulating the phosphorylation of Drp1 at S616 [<xref ref-type="bibr" rid="CR37">37</xref>]. Consistent with these results, the induction of mitochondrial fission and apoptosis by the combination of CQ/IH was associated with the activation of CaMKII mediating phosphorylation (S616) and the mitochondrial translocation of Drp1. Firstly, combined treatment with CQ/IH induces the phosphorylation of CaMKII (Thr286) and Drp1(S616). Secondly, mitochondrial translocation of Drp1, mitochondrial fission, and apoptosis were blocked in cells overexpressing CaMKII<sup>T286A</sup> (occluding Thr286 phosphorylation) but promoted in cells overexpressing CaMKII<sup>T286D</sup> (mimicking Thr286 phosphorylation) in response to the CQ/IH combination. Thirdly, the knockdown of CaMKII with siRNA significantly blocked the mitochondrial translocation of Drp1, mitochondrial fission, and apoptosis mediated by the combination of CQ/IH. Very surprisingly, we discovered that the CQ/IH combination led to the mitochondrial translocation of CaMKII. It is much more possible that the phosphorylation of CaMKII (Thr286) and its mitochondrial translocation may serve as switches which determine the phosphorylation (S616) and mitochondrial translocation of Drp1 during mitochondrial fission and apoptosis induced by the CQ/IH combination, as shown by a variety of evidence. The first is that the combination of CQ/IH led to the phosphorylation of both CaMKII (Thr286) and Drp1 (S616) and their mitochondrial translocation. Secondly, the combination of CQ/IH promoted the interaction and colocalization of CaMKII and Drp1 in the mitochondria. Thirdly, the mitochondrial translocation of CaMKII and Drp1, mitochondrial fission, and apoptosis were blocked in cells overexpressing CaMKII<sup>T286A</sup> but promoted in cells overexpressing CaMKII<sup>T286D</sup>, in response to the combination CQ/IH. The final piece of evidence is that the knockdown of CaMKII with siRNA significantly blocked the mitochondrial translocation of CaMKII and Drp1, mitochondrial fission, and apoptosis mediated by the CQ/IH combination. To the best of our knowledge, this is the first report finding that the mitochondrial translocation of CaMKII is required for combination-mediated Drp1-dependent mitochondrial fission and cell death.</p><p id="Par45">Several lines of evidence demonstrate that ROS play critical roles in CaMKII activation-mediated apoptosis [<xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR51">51</xref>]. ROS, including O<sub>2</sub><sup>•-</sup>, H<sub>2</sub>O<sub>2</sub>, and OH·, are recognized as signaling molecules that are mobilized in response to various apoptotic stimuli [<xref ref-type="bibr" rid="CR52">52</xref>]. In this study, we employed three antioxidants—TBAP, catalase, and sodium formate, which primarily act on O<sub>2</sub><sup>• -</sup>, H<sub>2</sub>O<sub>2</sub>, and OH·, respectively—to investigate the involvement of individual ROS in combination-mediated mitochondrial fission, apoptosis, and perturbations in signaling events. Our results suggest that O<sub>2</sub><sup>• -</sup> plays an essential role in combination-mediated apoptosis in TNBC cells, based on several lines of evidence. The first is that TBAP, a O<sub>2</sub><sup>•-</sup> scavenger, essentially abrogated CQ/IH-mediated ROS generation in TNBC cells, whereas catalase (a H<sub>2</sub>O<sub>2</sub> scavenger) and SF (a OH· scavenger) failed to do so. Secondly, TBAP, but not catalase and SF, noticeably prevented phosphorylation of CaMKII (Thr286) and Drp1 (S616) and their mitochondrial translocation mediated by CQ/IH. Thirdly, TBAP, but not catalase and SF, markedly attenuated colocalization of CaMKII and Drp1 at mitochondria induced by CQ/IH. Finally, TBAP, but not catalase and SF, significantly inhibited mitochondrial fission and apoptosis mediated by CQ/IH. Together, these findings suggest that O<sub>2</sub><sup>• -</sup> is primarily responsible not only for CQ/IH-mediated lethality in TNBC cells but also for perturbations in the CaMKII/Drp1 signaling pathway.</p></sec><sec id="Sec24"><title>Conclusions</title><p id="Par46">In summary, the present findings demonstrate for the first time that the inhibition of autophagy/mitophagy by CQ enhanced IH-mediated apoptosis by triggering mitochondrial fission in TNBC cells. Our findings highlight a critical role of ROS-mediating CaMKII/Drp1 signaling in the regulation of mitochondrial fission and apoptosis induced by the combination of CQ/IH. These findings support a hypothetical model of the synergistic effects of CQ/IH (Fig. <xref rid="Fig6" ref-type="fig">6</xref>e). In this model, the CQ/IH combination induces production of ROS, particularly the O<sub>2</sub><sup>•-</sup> free radical. This, in turn, promotes the phosphorylation of CaMKII/Drp1 and their mitochondrial translocation, leading to the mitochondrial translocation of Bax; this culminated in mitochondrial fission, caspase activation, and apoptosis. Our findings also suggest that IH has the potential for further development as a novel chemotherapeutic agent, and that a combination of IH with classic autophagy/mitophagy inhibitor could represent a novel therapeutic strategy for the treatment of TNBC.</p></sec><sec sec-type="supplementary-material"><title>Additional file</title><sec id="Sec25"><p><supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13046_2019_1201_MOESM1_ESM.docx"><label>Additional file 1:</label><caption><p><bold>Figure S1.</bold> Combined treatment with CQ/IH induces apoptosis in BT549 cells. <bold>Figure S2.</bold> Excessive accumulation of mitophagosomes contributes to apoptosis induced by combination of CQ/IH in MDA-MB-231 cells. <bold>Figure S3</bold>. Combined treatment with CQ/IH induces phosphorylation of Drp1 (Ser616) and mitochondrial translocation of Drp1 in BT549 cells. <bold>Figure S4</bold>. Combined treatment with CQ/IH induces the colocalization of Drp1 and Bax at mitochondria in MDA-MB-231 cells. <bold>Figure S5</bold>. Combined treatment with CQ/IH induces phosphorylation of CaMKII (Thr286) and mitochondrial translocation of CaMKII (Thr286) in BT549 cells. <bold>Figure S6</bold>. CaMKII mutation blocks mitochondrial fission and apoptosis induced by combination of CQ/IH. <bold>Figure S7</bold>. Knockdown of CaMKII blocks mitochondrial fission and apoptosis induced by combination of CQ/IH. <bold>Figure S8</bold>. Effects of antioxidants on CQ/IH-induced ROS generation, mitochondrial fission, apoptosis, and cell signaling proteins. (DOCX 4596 kb)</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CaMKII</term><def><p id="Par5">Calmodulin-dependent protein kinase II</p></def></def-item><def-item><term>CQ</term><def><p id="Par6">Chloroquine</p></def></def-item><def-item><term>Drp1</term><def><p id="Par7">Dynamin-related protein 1</p></def></def-item><def-item><term>IH</term><def><p id="Par8">Isorhamnetin</p></def></def-item><def-item><term>ROS</term><def><p id="Par9">Reactive oxygen species</p></def></def-item><def-item><term>TNBC</term><def><p id="Par10">Triple-negative breast cancer</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>This work was funded by National Natural Science Foundation of China (31571425, 81402970; 81402013).</p><sec id="FPar1"><title>Funding</title><p id="Par47">See acknowledgements.</p></sec><sec id="FPar2" sec-type="data-availability"><title>Availability of data and materials</title><p id="Par48">All data generated or analyzed during this study are included in this published article and its supplementary information files.</p></sec></ack><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>NG. Designed the study and wrote manuscript. JH. Designed the study, performed all the experiments, and analyzed and interpreted the data. YZ. Performed the experiments and revised manuscript. XJ. Performed the experiments (Cell culture and flow cytometry). HZ. Performed the experiments (Identified the structure of IH, MTT assay). ZG. Edited manuscript. YL. Performed the experiments (Western blot). RF. Performed the experiments (IP and immunofluorescence). LL. Performed the experiments (Apoptosis detection). JL. Performed the experiments (MTT assay). HC. Designed the study and provided critical revision and intellectual content. All authors read and approved the final manuscript.</p></notes><notes><title>Ethics approval</title><p id="Par49">The animal experiments conducted strictly in accordance with the Animal Study Guidelines of Army Medical University.</p></notes><notes><title>Consent for publication</title><p id="Par50">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par51">The authors declare that they have no competing interests.</p></notes><notes><title>Publisher’s Note</title><p id="Par52">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagini</surname><given-names>S</given-names></name></person-group><article-title>Breast Cancer: current molecular therapeutic targets and new players</article-title><source>Anti Cancer Agents Med Chem</source><year>2017</year><volume>17</volume><fpage>152</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.2174/1871520616666160502122724</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietze</surname><given-names>EC</given-names></name><name><surname>Sistrunk</surname><given-names>C</given-names></name><name><surname>Miranda-Carboni</surname><given-names>G</given-names></name><name><surname>O'Regan</surname><given-names>R</given-names></name><name><surname>Seewaldt</surname><given-names>VL</given-names></name></person-group><article-title>Triple-negative breast cancer in African-American women: disparities versus biology</article-title><source>Nat Rev Cancer</source><year>2015</year><volume>15</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/nrc3896</pub-id><pub-id pub-id-type="pmid">25673085</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Rosol</surname><given-names>TJ</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name></person-group><article-title>Triple-negative breast cancer: is there a treatment on the horizon?</article-title><source>Oncotarget.</source><year>2017</year><volume>8</volume><fpage>1913</fpage><lpage>1924</lpage><pub-id pub-id-type="pmid">27765921</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Mu</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer</article-title><source>Oncol Lett</source><year>2018</year><volume>16</volume><fpage>4984</fpage><lpage>4996</lpage><pub-id pub-id-type="pmid">30250564</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>KH</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name></person-group><article-title>Predicting and overcoming chemotherapeutic resistance in breast Cancer</article-title><source>Adv Exp Med Biol</source><year>2017</year><volume>1026</volume><fpage>59</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1007/978-981-10-6020-5_4</pub-id><pub-id pub-id-type="pmid">29282680</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunez</surname><given-names>C</given-names></name><name><surname>Capelo</surname><given-names>JL</given-names></name><name><surname>Igrejas</surname><given-names>G</given-names></name><name><surname>Alfonso</surname><given-names>A</given-names></name><name><surname>Botana</surname><given-names>LM</given-names></name><name><surname>Lodeiro</surname><given-names>C</given-names></name></person-group><article-title>An overview of the effective combination therapies for the treatment of breast cancer</article-title><source>Biomaterials.</source><year>2016</year><volume>97</volume><fpage>34</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.04.027</pub-id><pub-id pub-id-type="pmid">27162073</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limpert</surname><given-names>AS</given-names></name><name><surname>Lambert</surname><given-names>LJ</given-names></name><name><surname>Bakas</surname><given-names>NA</given-names></name><name><surname>Bata</surname><given-names>N</given-names></name><name><surname>Brun</surname><given-names>SN</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name><name><surname>Cosford</surname><given-names>NDP</given-names></name></person-group><article-title>Autophagy in Cancer: regulation by small molecules</article-title><source>Trends Pharmacol Sci</source><year>2018</year><volume>39</volume><fpage>1021</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2018.10.004</pub-id><pub-id pub-id-type="pmid">30454769</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Sun CY, Zhang QY, Zheng GJ, Feng B. Autophagy and its potent modulators from phytochemicals in cancer treatment. Cancer Chemother Pharmacol. 2018.</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagotto</surname><given-names>A</given-names></name><name><surname>Pilotto</surname><given-names>G</given-names></name><name><surname>Mazzoldi</surname><given-names>EL</given-names></name><name><surname>Nicoletto</surname><given-names>MO</given-names></name><name><surname>Frezzini</surname><given-names>S</given-names></name><name><surname>Pasto</surname><given-names>A</given-names></name><name><surname>Amadori</surname><given-names>A</given-names></name></person-group><article-title>Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells</article-title><source>Cell Death Dis</source><year>2017</year><volume>8</volume><fpage>e2943</fpage><pub-id pub-id-type="doi">10.1038/cddis.2017.327</pub-id><pub-id pub-id-type="pmid">28726781</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Golden</surname><given-names>EB</given-names></name><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Agarwal</surname><given-names>P</given-names></name><name><surname>Gaffney</surname><given-names>KJ</given-names></name><name><surname>Petasis</surname><given-names>NA</given-names></name><name><surname>Chen</surname><given-names>TC</given-names></name><name><surname>Hofman</surname><given-names>FM</given-names></name><name><surname>Louie</surname><given-names>SG</given-names></name><name><surname>Schonthal</surname><given-names>AH</given-names></name></person-group><article-title>Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors</article-title><source>Cancer Lett</source><year>2012</year><volume>325</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2012.05.030</pub-id><pub-id pub-id-type="pmid">22664238</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefort</surname><given-names>S</given-names></name><name><surname>Joffre</surname><given-names>C</given-names></name><name><surname>Kieffer</surname><given-names>Y</given-names></name><name><surname>Givel</surname><given-names>AM</given-names></name><name><surname>Bourachot</surname><given-names>B</given-names></name><name><surname>Zago</surname><given-names>G</given-names></name><name><surname>Bieche</surname><given-names>I</given-names></name><name><surname>Dubois</surname><given-names>T</given-names></name><name><surname>Meseure</surname><given-names>D</given-names></name><name><surname>Vincent-Salomon</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers</article-title><source>Autophagy.</source><year>2014</year><volume>10</volume><fpage>2122</fpage><lpage>2142</lpage><pub-id pub-id-type="doi">10.4161/15548627.2014.981788</pub-id><pub-id pub-id-type="pmid">25427136</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>SL</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Lin</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>CC</given-names></name><name><surname>Chuang</surname><given-names>CH</given-names></name></person-group><article-title>Comparing the metabolism of quercetin in rats, mice and gerbils</article-title><source>Eur J Nutr</source><year>2016</year><volume>55</volume><fpage>413</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1007/s00394-015-0862-9</pub-id><pub-id pub-id-type="pmid">25691233</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruan</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group><article-title>Autophagy inhibition enhances isorhamnetininduced mitochondriadependent apoptosis in nonsmall cell lung cancer cells</article-title><source>Mol Med Rep</source><year>2015</year><volume>12</volume><fpage>5796</fpage><lpage>5806</lpage><pub-id pub-id-type="doi">10.3892/mmr.2015.4148</pub-id><pub-id pub-id-type="pmid">26238746</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name></person-group><article-title>The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells</article-title><source>Chem Biol Interact</source><year>2007</year><volume>167</volume><fpage>153</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2007.02.006</pub-id><pub-id pub-id-type="pmid">17368593</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>L</given-names></name><name><surname>Manu</surname><given-names>KA</given-names></name><name><surname>Shanmugam</surname><given-names>MK</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Siveen</surname><given-names>KS</given-names></name><name><surname>Vali</surname><given-names>S</given-names></name><name><surname>Kapoor</surname><given-names>S</given-names></name><name><surname>Abbasi</surname><given-names>T</given-names></name><name><surname>Surana</surname><given-names>R</given-names></name><name><surname>Smoot</surname><given-names>DT</given-names></name><etal></etal></person-group><article-title>Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor gamma activation pathway in gastric cancer</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>38028</fpage><lpage>38040</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.388702</pub-id><pub-id pub-id-type="pmid">22992727</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saud</surname><given-names>SM</given-names></name><name><surname>Young</surname><given-names>MR</given-names></name><name><surname>Jones-Hall</surname><given-names>YL</given-names></name><name><surname>Ileva</surname><given-names>L</given-names></name><name><surname>Evbuomwan</surname><given-names>MO</given-names></name><name><surname>Wise</surname><given-names>J</given-names></name><name><surname>Colburn</surname><given-names>NH</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Bobe</surname><given-names>G</given-names></name></person-group><article-title>Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and beta-catenin</article-title><source>Cancer Res</source><year>2013</year><volume>73</volume><fpage>5473</fpage><lpage>5484</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-0525</pub-id><pub-id pub-id-type="pmid">23824743</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>DE</given-names></name><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Son</surname><given-names>JE</given-names></name><name><surname>Seo</surname><given-names>SK</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jung</surname><given-names>SK</given-names></name><name><surname>Heo</surname><given-names>YS</given-names></name><name><surname>Mottamal</surname><given-names>M</given-names></name><name><surname>Bode</surname><given-names>AM</given-names></name><etal></etal></person-group><article-title>Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K</article-title><source>Cancer Prev Res (Phila)</source><year>2011</year><volume>4</volume><fpage>582</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-11-0032</pub-id><pub-id pub-id-type="pmid">21330379</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Meng</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name></person-group><article-title>Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogenactivated protein kinase kinase signaling pathways</article-title><source>Mol Med Rep</source><year>2015</year><volume>12</volume><fpage>6745</fpage><lpage>6751</lpage><pub-id pub-id-type="doi">10.3892/mmr.2015.4269</pub-id><pub-id pub-id-type="pmid">26502751</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>HW</given-names></name><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Fu</surname><given-names>RQ</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>YN</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name><name><surname>Luo</surname><given-names>QS</given-names></name><etal></etal></person-group><article-title>Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kgamma mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>11255</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-29308-7</pub-id><pub-id pub-id-type="pmid">30050147</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>N</given-names></name><name><surname>Kramer</surname><given-names>L</given-names></name><name><surname>Rahmani</surname><given-names>M</given-names></name><name><surname>Dent</surname><given-names>P</given-names></name><name><surname>Grant</surname><given-names>S</given-names></name></person-group><article-title>The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism</article-title><source>Mol Pharmacol</source><year>2006</year><volume>70</volume><fpage>645</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1124/mol.106.024505</pub-id><pub-id pub-id-type="pmid">16672643</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Budhraja</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name></person-group><article-title>Mitochondrial translocation and interaction of cofilin and Drp1 are required for erucin-induced mitochondrial fission and apoptosis</article-title><source>Oncotarget.</source><year>2015</year><volume>6</volume><fpage>1834</fpage><lpage>1849</lpage><pub-id pub-id-type="pmid">25595902</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name></person-group><article-title>Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells</article-title><source>Blood Cancer J</source><year>2013</year><volume>3</volume><fpage>e108</fpage><pub-id pub-id-type="doi">10.1038/bcj.2013.7</pub-id><pub-id pub-id-type="pmid">23584398</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>C</given-names></name><name><surname>Delivani</surname><given-names>P</given-names></name><name><surname>Cullen</surname><given-names>SP</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release</article-title><source>Mol Cell</source><year>2008</year><volume>31</volume><fpage>570</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.08.002</pub-id><pub-id pub-id-type="pmid">18722181</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname><given-names>SL</given-names></name></person-group><article-title>Mitochondrial dynamics--mitochondrial fission and fusion in human diseases</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><fpage>2236</fpage><lpage>2251</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1215233</pub-id><pub-id pub-id-type="pmid">24304053</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis</article-title><source>Mol Cell</source><year>2008</year><volume>29</volume><fpage>409</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.02.005</pub-id><pub-id pub-id-type="pmid">18313377</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Gutierrez Cortes</surname><given-names>N</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Yoon</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>CaMKII induces permeability transition through Drp1 phosphorylation during chronic beta-AR stimulation</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>13189</fpage><pub-id pub-id-type="doi">10.1038/ncomms13189</pub-id><pub-id pub-id-type="pmid">27739424</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takemoto-Kimura</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Horigane</surname><given-names>SI</given-names></name><name><surname>Kamijo</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Sakamoto</surname><given-names>M</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name></person-group><article-title>Calmodulin kinases: essential regulators in health and disease</article-title><source>J Neurochem</source><year>2017</year><volume>141</volume><fpage>808</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1111/jnc.14020</pub-id><pub-id pub-id-type="pmid">28295333</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>S</given-names></name><name><surname>Ruff</surname><given-names>HM</given-names></name><name><surname>Weber</surname><given-names>SL</given-names></name><name><surname>Bellmann</surname><given-names>S</given-names></name><name><surname>Sowa</surname><given-names>T</given-names></name><name><surname>Schulte</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name><name><surname>Grandi</surname><given-names>E</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name><name><surname>Backs</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Reactive oxygen species-activated ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and ca overload</article-title><source>Circ Res</source><year>2011</year><volume>108</volume><fpage>555</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.221911</pub-id><pub-id pub-id-type="pmid">21252154</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>ME</given-names></name></person-group><article-title>Oxidant stress promotes disease by activating CaMKII</article-title><source>J Mol Cell Cardiol</source><year>2015</year><volume>89</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.10.014</pub-id><pub-id pub-id-type="pmid">26475411</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>N</given-names></name><name><surname>Rahmani</surname><given-names>M</given-names></name><name><surname>Dent</surname><given-names>P</given-names></name><name><surname>Grant</surname><given-names>S</given-names></name></person-group><article-title>2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process</article-title><source>Oncogene.</source><year>2005</year><volume>24</volume><fpage>3797</fpage><lpage>3809</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1208530</pub-id><pub-id pub-id-type="pmid">15782127</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maghzal</surname><given-names>GJ</given-names></name><name><surname>Krause</surname><given-names>KH</given-names></name><name><surname>Stocker</surname><given-names>R</given-names></name><name><surname>Jaquet</surname><given-names>V</given-names></name></person-group><article-title>Detection of reactive oxygen species derived from the family of NOX NADPH oxidases</article-title><source>Free Radic Biol Med</source><year>2012</year><volume>53</volume><fpage>1903</fpage><lpage>1918</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.09.002</pub-id><pub-id pub-id-type="pmid">22982596</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Hwang SY, Siow YL, Au-Yeung KK, House J, O K: Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. Am J Physiol Renal Physiol 2011; 300:F189–F198.</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talukdar</surname><given-names>S</given-names></name><name><surname>Pradhan</surname><given-names>AK</given-names></name><name><surname>Bhoopathi</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>XN</given-names></name><name><surname>August</surname><given-names>LA</given-names></name><name><surname>Windle</surname><given-names>JJ</given-names></name><name><surname>Sarkar</surname><given-names>D</given-names></name><name><surname>Furnari</surname><given-names>FB</given-names></name><name><surname>Cavenee</surname><given-names>WK</given-names></name><name><surname>Das</surname><given-names>SK</given-names></name><etal></etal></person-group><article-title>MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>5768</fpage><lpage>5773</lpage><pub-id pub-id-type="doi">10.1073/pnas.1721650115</pub-id><pub-id pub-id-type="pmid">29760085</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>GJ</given-names></name></person-group><article-title>Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment</article-title><source>J Hematol Oncol</source><year>2017</year><volume>10</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.1186/s13045-017-0436-9</pub-id><pub-id pub-id-type="pmid">28279189</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>GJ</given-names></name></person-group><article-title>Molecular machinery underlying the autophagic regulation by MDA-9/Syntenin leading to anoikis resistance of tumor cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2018</year><volume>115</volume><fpage>E7652</fpage><lpage>E7653</lpage><pub-id pub-id-type="doi">10.1073/pnas.1810152115</pub-id><pub-id pub-id-type="pmid">30087191</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Xing</surname><given-names>D</given-names></name></person-group><article-title>Drp1, Mff, Fis1, and MiD51 are coordinated to mediate mitochondrial fission during UV irradiation-induced apoptosis</article-title><source>FASEB J</source><year>2016</year><volume>30</volume><fpage>466</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1096/fj.15-274258</pub-id><pub-id pub-id-type="pmid">26432782</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bo</surname><given-names>T</given-names></name><name><surname>Yamamori</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Sakai</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Inanami</surname><given-names>O</given-names></name></person-group><article-title>Calmodulin-dependent protein kinase II (CaMKII) mediates radiation-induced mitochondrial fission by regulating the phosphorylation of dynamin-related protein 1 (Drp1) at serine 616</article-title><source>Biochem Biophys Res Commun</source><year>2018</year><volume>495</volume><fpage>1601</fpage><lpage>1607</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.12.012</pub-id><pub-id pub-id-type="pmid">29217195</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ban-Ishihara</surname><given-names>R</given-names></name><name><surname>Ishihara</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name><name><surname>Ishihara</surname><given-names>N</given-names></name></person-group><article-title>Dynamics of nucleoid structure regulated by mitochondrial fission contributes to cristae reformation and release of cytochrome c</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>11863</fpage><lpage>11868</lpage><pub-id pub-id-type="doi">10.1073/pnas.1301951110</pub-id><pub-id pub-id-type="pmid">23821750</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name></person-group><article-title>C-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death</article-title><source>Cell Death Dis</source><year>2017</year><volume>8</volume><fpage>e3117</fpage><pub-id pub-id-type="doi">10.1038/cddis.2017.524</pub-id><pub-id pub-id-type="pmid">29022905</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>CH</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>MC</given-names></name><name><surname>Wei</surname><given-names>CC</given-names></name><name><surname>Liao</surname><given-names>HD</given-names></name><name><surname>Lin</surname><given-names>RC</given-names></name><name><surname>Tu</surname><given-names>WY</given-names></name><name><surname>Kao</surname><given-names>TC</given-names></name><name><surname>Hsu</surname><given-names>CM</given-names></name><name><surname>Cheng</surname><given-names>JT</given-names></name><etal></etal></person-group><article-title>GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e49112</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0049112</pub-id><pub-id pub-id-type="pmid">23185298</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CR</given-names></name><name><surname>Blackstone</surname><given-names>C</given-names></name></person-group><article-title>Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>21583</fpage><lpage>21587</lpage><pub-id pub-id-type="doi">10.1074/jbc.C700083200</pub-id><pub-id pub-id-type="pmid">17553808</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taguchi</surname><given-names>N</given-names></name><name><surname>Ishihara</surname><given-names>N</given-names></name><name><surname>Jofuku</surname><given-names>A</given-names></name><name><surname>Oka</surname><given-names>T</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name></person-group><article-title>Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>11521</fpage><lpage>11529</lpage><pub-id pub-id-type="doi">10.1074/jbc.M607279200</pub-id><pub-id pub-id-type="pmid">17301055</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korytowski</surname><given-names>W</given-names></name><name><surname>Basova</surname><given-names>LV</given-names></name><name><surname>Pilat</surname><given-names>A</given-names></name><name><surname>Kernstock</surname><given-names>RM</given-names></name><name><surname>Girotti</surname><given-names>AW</given-names></name></person-group><article-title>Permeabilization of the mitochondrial outer membrane by Bax/truncated bid (tBid) proteins as sensitized by cardiolipin hydroperoxide translocation: mechanistic implications for the intrinsic pathway of oxidative apoptosis</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>26334</fpage><lpage>26343</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.188516</pub-id><pub-id pub-id-type="pmid">21642428</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>W</given-names></name><name><surname>Sheng</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Dynamin-related protein 1-mediated mitochondrial fission contributes to IR-783-induced apoptosis in human breast cancer cells</article-title><source>J Cell Mol Med</source><year>2018</year><volume>22</volume><fpage>4474</fpage><lpage>4485</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13749</pub-id><pub-id pub-id-type="pmid">29993201</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montessuit</surname><given-names>S</given-names></name><name><surname>Somasekharan</surname><given-names>SP</given-names></name><name><surname>Terrones</surname><given-names>O</given-names></name><name><surname>Lucken-Ardjomande</surname><given-names>S</given-names></name><name><surname>Herzig</surname><given-names>S</given-names></name><name><surname>Schwarzenbacher</surname><given-names>R</given-names></name><name><surname>Manstein</surname><given-names>DJ</given-names></name><name><surname>Bossy-Wetzel</surname><given-names>E</given-names></name><name><surname>Basanez</surname><given-names>G</given-names></name><name><surname>Meda</surname><given-names>P</given-names></name><name><surname>Martinou</surname><given-names>JC</given-names></name></person-group><article-title>Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization</article-title><source>Cell.</source><year>2010</year><volume>142</volume><fpage>889</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.08.017</pub-id><pub-id pub-id-type="pmid">20850011</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YY</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Zhe</surname><given-names>H</given-names></name></person-group><article-title>The emerging role of CaMKII in cancer</article-title><source>Oncotarget.</source><year>2015</year><volume>6</volume><fpage>11725</fpage><lpage>11734</lpage><pub-id pub-id-type="pmid">25961153</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiazzi</surname><given-names>A</given-names></name><name><surname>Bassani</surname><given-names>RA</given-names></name><name><surname>Escobar</surname><given-names>AL</given-names></name><name><surname>Palomeque</surname><given-names>J</given-names></name><name><surname>Valverde</surname><given-names>CA</given-names></name><name><surname>Vila Petroff</surname><given-names>M</given-names></name><name><surname>Bers</surname><given-names>DM</given-names></name></person-group><article-title>Chasing cardiac physiology and pathology down the CaMKII cascade</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2015</year><volume>308</volume><fpage>H1177</fpage><lpage>H1191</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00007.2015</pub-id><pub-id pub-id-type="pmid">25747749</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczak</surname><given-names>ED</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name></person-group><article-title>CaMKII oxidative activation and the pathogenesis of cardiac disease</article-title><source>J Mol Cell Cardiol</source><year>2014</year><volume>73</volume><fpage>112</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.02.004</pub-id><pub-id pub-id-type="pmid">24530899</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>LJ</given-names></name><name><surname>Klutho</surname><given-names>PJ</given-names></name><name><surname>Scott</surname><given-names>JA</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Luczak</surname><given-names>ED</given-names></name><name><surname>Dibbern</surname><given-names>ME</given-names></name><name><surname>Prasad</surname><given-names>AM</given-names></name><name><surname>Jaffer</surname><given-names>OA</given-names></name><name><surname>Venema</surname><given-names>AN</given-names></name><name><surname>Nguyen</surname><given-names>EK</given-names></name><etal></etal></person-group><article-title>Oxidative activation of the ca(2+)/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis</article-title><source>Vasc Pharmacol</source><year>2014</year><volume>60</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.vph.2014.01.001</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dilshara</surname><given-names>MG</given-names></name><name><surname>Jayasooriya</surname><given-names>R</given-names></name><name><surname>Molagoda</surname><given-names>IMN</given-names></name><name><surname>Jeong</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>SR</given-names></name><name><surname>Kim</surname><given-names>GY</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name></person-group><article-title>Silibinin sensitizes TRAIL-mediated apoptosis by upregulating DR5 through ROS-induced endoplasmic reticulum stress-ca(2+)-CaMKII-Sp1 pathway</article-title><source>Oncotarget.</source><year>2018</year><volume>9</volume><fpage>10324</fpage><lpage>10342</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.23129</pub-id><pub-id pub-id-type="pmid">29535810</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toledo</surname><given-names>FD</given-names></name><name><surname>Perez</surname><given-names>LM</given-names></name><name><surname>Basiglio</surname><given-names>CL</given-names></name><name><surname>Ochoa</surname><given-names>JE</given-names></name><name><surname>Sanchez Pozzi</surname><given-names>EJ</given-names></name><name><surname>Roma</surname><given-names>MG</given-names></name></person-group><article-title>The ca(2)(+)-calmodulin-ca(2)(+)/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes</article-title><source>Arch Toxicol</source><year>2014</year><volume>88</volume><fpage>1695</fpage><lpage>1709</lpage><pub-id pub-id-type="doi">10.1007/s00204-014-1219-5</pub-id><pub-id pub-id-type="pmid">24614978</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>XZ</given-names></name><name><surname>Wu</surname><given-names>SN</given-names></name><name><surname>Wang</surname><given-names>HG</given-names></name><name><surname>Zhang</surname><given-names>JL</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>TH</given-names></name></person-group><article-title>Combining TRAIL and liquiritin exerts synergistic effects against human gastric cancer cells and xenograft in nude mice through potentiating apoptosis and ROS generation</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>93</volume><fpage>948</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.06.095</pub-id><pub-id pub-id-type="pmid">28715876</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000105 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000105 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:6540563
|texte= ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:31138329" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |